US20090069797A1 - Bipolar devices for modification of airways by transfer of energy - Google Patents

Bipolar devices for modification of airways by transfer of energy Download PDF

Info

Publication number
US20090069797A1
US20090069797A1 US12/206,591 US20659108A US2009069797A1 US 20090069797 A1 US20090069797 A1 US 20090069797A1 US 20659108 A US20659108 A US 20659108A US 2009069797 A1 US2009069797 A1 US 2009069797A1
Authority
US
United States
Prior art keywords
airway
electrodes
energy
active regions
basket
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/206,591
Inventor
Christopher James Danek
Bryan Loomas
Michael Biggs
Keith M. Burger
Dave Haugaard
Thomas Keast
John Arthur Ross
Michael D. Laufer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Asthmatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/833,550 external-priority patent/US6273907B1/en
Priority claimed from US08/994,064 external-priority patent/US6083255A/en
Priority claimed from US09/003,750 external-priority patent/US5972026A/en
Priority claimed from US09/224,937 external-priority patent/US6200333B1/en
Priority claimed from US09/260,401 external-priority patent/US6283988B1/en
Priority claimed from US09/296,040 external-priority patent/US6411852B1/en
Priority claimed from US09/349,715 external-priority patent/US6488673B1/en
Priority to US12/206,591 priority Critical patent/US20090069797A1/en
Application filed by Asthmatx Inc filed Critical Asthmatx Inc
Publication of US20090069797A1 publication Critical patent/US20090069797A1/en
Assigned to BRONCUS TECHNOLOGIES, INC. reassignment BRONCUS TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LAUFER, MICHAEL D., BIGGS, MICHAEL, BURGER, KEITH M., DANEK, CHRISTOPHER JAMES, HAUGAARD, DAVE, KEAST, THOMAS, ROSS, JOHN ARTHUR, LOOMAS, BRYAN
Assigned to ASTHMATX, INC. reassignment ASTHMATX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRONCUS TECHNOLOGIES, INC.
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASTHMATX, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/06Electrodes for high-frequency therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/08Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00115Electrical control of surgical instruments with audible or visual output
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22062Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00541Lung or bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B2018/044Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B2018/044Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
    • A61B2018/046Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1407Loop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B2018/1807Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation

Definitions

  • the invention relates to a device for treating lung disease, and more particularly, the invention relates to a device for transferring energy into airway tissue such as that found in the airways of human lungs. This includes heating and applying RF energy to the airway. In the airways of the lung, the transfer of energy into the airway tissue stiffens that tissue or reduces the ability of the airways to constrict. In general the treatment reduces the resistance to the flow of air through the airway.
  • Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe.
  • Asthma is a chronic disorder, primarily characterized by persistent airway inflammation.
  • asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
  • Asthma stimuli may be allergenic or non-allergenic.
  • allergenic stimuli include pollen, pet dander, dust mites, bacterial or viral infection, mold, dust, or airborne pollutants; non-allergenic stimuli include exercise or exposure to cold, dry air.
  • asthma can also lead to remodeling of the airway wall (i.e., structural changes such as thickening or edema) which can further affect the function of the airway wall and influence airway hyperresponsiveness.
  • Other physiologic changes associated with asthma include excess mucus production, and if the asthma is severe, mucus plugging, as well as ongoing epithelial denudation and repair.
  • Epithelial denudation exposes the underlying tissue to substances that would not normally come in contact with them, further reinforcing the cycle of cellular damage and inflammatory response.
  • asthma symptoms include recurrent episodes of shortness of breath (dyspnea), wheezing, chest tightness, and cough.
  • dyspnea shortness of breath
  • wheezing wheezing
  • chest tightness chest tightness
  • cough Currently, asthma is managed by a combination of stimulus avoidance and pharmacology.
  • Stimulus avoidance is accomplished via systematic identification and minimization of contact with each type of stimuli. It may, however, be impractical and not always helpful to avoid all potential stimuli.
  • Asthma is managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both approaches require repeated and regular use of the prescribed drugs. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. Patient compliance with pharmacologic management and stimulus avoidance is often a barrier to successful asthma management.
  • the present invention relates to a device for treating airway tissue within the lungs by transfer of energy into the walls of the airway to reduce plugging of the airway, to prevent the airway from being able to constrict, to increase the inner airway diameter, or to reduce resistance to flow through the airway.
  • the invention is particularly directed to the treatment of the airways in the lungs to reduce the effects of asthma and other lung disease.
  • One variation of the invention includes the transfer of energy to the airway wall via the application of heat.
  • an energy transfer apparatus for treating conditions of the lungs by decreasing airway responsiveness includes transferring energy into an airway wall to alter the airway wall in such a manner that the responsiveness of the airway is reduced.
  • the inventive device is an energy transfer apparatus which facilitates energy transfer with a mass of tissue within the airways of a lung.
  • the inventive device is sized to enter the bronchus or bronchiole of a human lung to conduct energy transfer with the airway tissue therein.
  • the inventive device may also be sized to fit within a bronchoscope.
  • the bronchoscope may have a channel with a diameter of preferably 2 mm or less.
  • a variation of the inventive device includes a flexible elongated body having a proximal portion and a distal portion with a lumen extending between the proximal and distal portions.
  • the flexible elongated body may be of sufficient stiffness to pass through a seal of a working channel of a bronchoscope and allow operation of the device through the working channel seal.
  • the device may include an expandable portion that is adjacent to a distal portion of the elongated body.
  • the expandable portion has a first state, e.g., a size, and a second state where the second state is radially expanded in size from the elongated body.
  • the device may include a temperature detecting element which is placed near to the expandable portion.
  • the device also includes at least one energy transfer element at an exterior of the expandable portion, where the energy transfer elements are configured to contact the wall of the bronchus or bronchiole when the expanded portion is in an expanded state.
  • the device may also include a deployment member that is configured to move the expandable portion between the first and second radially expanded states.
  • the deployment member may extend between the expandable portion and the proximal portion of the elongated body.
  • the inventive device may further include a distal tip located at a distal end of the apparatus.
  • One variation of the inventive device includes an expandable portion that has a diameter of less than 15 mm when in a second expanded state.
  • Another variation of the invention includes an expandable portion which includes pre-shaped tines.
  • Such tines are configured to be in a first state within an elongated body and, when advanced out of the elongated body, to expand into a second expanded state.
  • the tines may be connected to each other with an expanding element to prevent the tines from entering multiple airways at a bifurcation.
  • Another variation of the invention includes an expandable portion comprised of a balloon.
  • This variation of the invention may include the use of a fluid which may expand the balloon into the second state.
  • Yet another variation of this invention includes the use of a heat generating element in the balloon which conducts heat to the fluid to heat an exterior of the balloon. In this variation, the exterior of the balloon serves as the energy transfer element.
  • a further variation of the inventive device includes an expandable portion which comprises a plurality of legs which forms a basket.
  • the legs of this variation may extend from a proximal joint that is found at an intersection of a distal portion of the elongated body to a distal joint that is adjacent to a distal tip.
  • Each leg may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg.
  • the center that is substantially parallel is usually referred to as the active region of the leg.
  • the legs of this variation may be spaced around a circumference of the elongated body to form a basket.
  • the legs of this variation may have a circular cross section or a rectangular cross section, or other non-axisymmetric cross sections.
  • the cross sections may be chosen to allow ready deployment from a first state to a second expanded state, while resisting out-of-plane bending which may distort the spacing of the legs or the contact of electrodes with the airway surface.
  • One variation of the invention includes a basket in which the distance between the proximal and distal joint is less than 35 mm when the basket is not expanded.
  • Another variation of this invention includes a basket that comprises four or five legs. In this case, the legs may be placed evenly around a circumference of the elongated body.
  • the legs may be found at intervals of 90 or 72 degrees.
  • Other variations of the invention include devices having less than four legs or more than five legs.
  • Another variation of this inventive device includes placing a temperature detecting element on one or on more legs. In this variation, the temperature of one leg may be monitored or the temperature of several legs may be independently monitored to control the energy delivery. In a further variation, multiple temperature sensing elements may be combined with independent control of energy to each leg. Both of these variations may also apply to a variation of the device having pre-shaped tines.
  • the legs may be soldered or made to adhere using adhesives to the elongated body at the proximal and distal ends.
  • Another variation of the invention includes a multi-lumen elongated body into which a portion of each leg is inserted. It is also contemplated that an elongated member may be reinforced via a reinforcing member. Such a reinforcing member may include a coiled or braided wire, polymeric insert, or any other similar reinforcing member.
  • the energy transfer element of the invention may include an element that directly heats tissue by delivering current such as an RF based electrode.
  • the RF electrode may be either bipolar or monopolar or a heated element that conductively heats tissue.
  • the frequency of the RF may be selected to be in the 400 kHz range or any other standard medical range used in electro-surgical applications.
  • the heated element may use AC or DC current to resistively heat the element.
  • RF energy may also be used to resistively heat the element.
  • An indirect method of heating includes a resistively heated element that conducts heat to the expandable portion or directly to the airway.
  • the invention may also include a combination of the types of electrodes mentioned above.
  • each of the energy transfer elements may be a RF electrode that is attached to each leg.
  • the electrode may be fastened by a heat shrink fastener.
  • a temperature detecting element may be placed on the leg and underneath the fastener.
  • a resistance heating element may be coiled around a portion of the leg.
  • a temperature detecting element may be placed underneath the coil.
  • Other examples of the energy transfer element include a polymeric heating element, an electrically conductive paint, or a printed flex circuit which are on a portion of the leg.
  • Another variation employs the basket leg itself as either a RF electrode or a heated element. In such cases, the temperature sensing element may be attached directly to a basket leg by soldering, welding, adhesive bonding, or other means.
  • Another variation of the invention includes a sheath slidably coupled to and exterior to the expandable portion.
  • the expandable portion may be resilient and self-expand into the second state when no longer confined by the sheath. For example, the sheath may be withdrawn in a proximal direction or the expandable portion may be advanced out of the sheath.
  • Yet another variation of the invention includes a deployment member comprising a handle adjacent to a proximal end of the elongated body.
  • the elongated body may be slidably attached to the handle.
  • the deployment member may also comprise a wire that extends from the handle through the lumen of the elongated body and is fixedly attached to the distal tip. This wire may also provide a current to the energy transfer members.
  • the elongated body, the wire, and the distal tip may be slidably moveable in a distal and proximal direction.
  • This variation of the deployment member may also include a stop configured to prevent distal movement of the wire beyond a deployment point. In this variation, beyond the deployment point, movement of the elongated body against the non-moving distal tip causes the expansion member to expand from a first state into a second expanded state.
  • a deployment member comprising a sheath that covers the elongated member and expandable portion and a handle at a proximal end of the sheath.
  • the sheath may be slidably attached to the handle while the elongated member is rigidly attached to the handle.
  • a wire may extend from said handle to a distal tip through a lumen of the elongated member.
  • the variation may include a first control member attached to the sheath and slidably attached to the handle where proximal movement of the first control member causes the sheath to retract on the elongated member and uncover the expandable portion.
  • This variation may also include a second control member which is attached to the wire where proximal movement of the second control member causes the distal tip and the expandable portion to retract against the non-moving elongated member and causes the expandable portion to radially expand into a second state.
  • Another variation of the invention includes a deployment member having force compensation or deflection limiting stops to prevent over-expansion of the expandable member when deployed within the body.
  • a variation of the invention includes placing a sheath exterior to the elongated body and expandable portion such that the expandable portion is placed within the sheath in a first unexpanded state. When the expandable portion is no longer restrained by the sheath, the expandable portion expands into its second state.
  • the invention may also include a control member moveably secured to the handle where the member is configured to advance the elongated body and the wire in the distal and proximal directions.
  • Another variation of the invention includes a detent means for maintaining the elongated body distally of the deployment point.
  • the control member may also be configured to frictionally maintain the elongated body distally of the deployment point. In these cases, the expandable portion will be in the second expanded state.
  • Other variations of the inventive device may include use of levers, control wheels, or screw mechanisms in place of a control member.
  • Another variation of the inventive device includes a distal tip that may be configured to prevent gouging of the airway tissue.
  • the distal tip may have a redundant joint to prevent separation of the tip from the apparatus.
  • the distal tip may also be sized to fit within a bronchoscope.
  • Another variation of the invention includes a central wire extending from the distal tip to the proximal portion of the device.
  • the wire may be configured to provide a current to the energy transfer elements.
  • a temperature detecting element may also be attached to the wire.
  • the inventive device may also be radiopaque or may have radiopaque elements.
  • Another variation of the invention includes providing a steering member in the device to deflect the distal tip of the apparatus in a desired direction.
  • the vision system may include a fiber-optic cable or a CCD chip.
  • Another variation of the invention includes providing a power supply configured to deliver energy through the energy transfer elements to the airway walls.
  • the power supply may be configured to include a high temperature shut off or one which shuts down if a minimum temperature is not detected within a predetermined time or if a minimum temperature slope is not detected during a predetermined time.
  • the invention further includes a kit comprising an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue and a generator configured to delivery energy to the energy transfer apparatus.
  • the kit may further include a bronchoscope.
  • the invention further includes an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue within a lung, the energy transfer apparatus having been rendered sterile for the purposes of prevention of infection of the lung.
  • the invention further includes a modified lung configured to have an artificially altered airway within the lung, the airway being artificially altered by transfer of energy to the airway such that the airway has a reduced ability to constrict, an increased airway diameter, a increase in resistance to plugging, and a decrease in resistance to airflow.
  • the present invention may be used for a treatment of asthma or other constriction or spasm of a bodily conduit by application of energy.
  • the treatment reduces the ability or propensity of the airway to contract, reduces plugging of the airway, increases the inner airway diameter, and/or reduces resistance to flow through the airway.
  • FIG. 1 is a cross sectional view of a medium sized bronchus in a healthy patient.
  • FIG. 2 is a cross sectional view of a bronchiole in a healthy patient.
  • FIG. 3 is a cross sectional view of the bronchus of FIG. 1 showing the remodeling and constriction occurring in an asthma patient.
  • FIG. 4 is an illustration of the lungs being treated with a device according to the present invention.
  • FIG. 5A is a partial side view of a variation of the inventive device having a plurality of wire shaped electrodes.
  • FIG. 5B is a cross sectional side view of another variation of a device having a plurality of wire shaped electrodes with a deployment wire attached to a distal tip of the device.
  • FIG. 5C shows a partial view of a variation of an elongated member of inventive device having a plurality of lumens for nesting the legs of the basket.
  • FIGS. 5D-5I illustrate a variation of the invention and a deployment member for deploying the device.
  • FIGS. 5J-5L illustrate examples of energy transfer elements of the device.
  • FIG. 5M shows a partial view of a thermocouple attached to a basket leg.
  • FIGS. 6A-6D illustrates distal joints of the invention.
  • FIG. 6E illustrates a proximal joint of the invention.
  • FIGS. 7A-7D illustrates a series and parallel wiring of legs of the basket.
  • FIGS. 8A-8C illustrate examples of variable thicknesses of legs of the basket.
  • FIGS. 9A-9D illustrate examples of a basket formed from a single sheet or piece of material.
  • FIG. 10 is a side cross sectional view of a variation of the inventive device having a balloon with electrodes positioned exterior to the balloon.
  • FIG. 11 is a partial side view of a variation of the inventive device having a balloon with heat generating elements positioned within the balloon for indirect heating of the tissue.
  • FIG. 12 is cross sectional view of the inventive device with electrodes and pre-shaped tines as the expandable member.
  • FIG. 13 is a cross sectional view of a variation of the inventive device with energy transfer elements positioned on expandable balloons.
  • FIG. 14 is an illustration of a variation of the inventive device with electrodes positioned in grooves.
  • FIG. 15 is an illustration of a variation of the inventive device with electrodes and a biasing element.
  • FIG. 16 is an illustration of another variation of the inventive device having electrodes and a biasing element.
  • FIG. 17 is a partial side view of a variation of the inventive device having electrodes exposed by cut away sections of an elongated member.
  • FIG. 18 is a partial side view of the inventive device with electrodes positioned on a loop shaped member.
  • FIG. 19 is a cross sectional view of a variation of the inventive device having a looped shaped electrode in an unexpanded position.
  • FIG. 20 is a cross sectional view of the variation of FIG. 19 with the looped shape electrode in an expanded position.
  • the inventive airway energy treatment may be used to reduce the ability of the airways to narrow or to reduce in diameter due to airway smooth muscle contraction.
  • This treatment to reduce the ability of the smooth muscle to contract lessens the severity of an asthma attack.
  • the reduction in the ability of smooth muscle to contract may be achieved by treating the smooth muscle itself or by treating other tissues which in turn influence smooth muscle contraction or the response of the airway to smooth muscle contraction.
  • Treatment may also reduce airway responsiveness or the tendency of the airway to narrow or to constrict in response to a stimulus.
  • the amount of smooth muscle surrounding the airway can be reduced by exposing the smooth muscle to energy which either kills the muscle cells or prevents these cells from replicating.
  • the reduction in smooth muscle reduces the ability of the smooth muscle to contract and to narrow the airway during a spasm.
  • the reduction in smooth muscle and surrounding tissue has the added potential benefit of increasing the caliber or diameter of the airways, reducing the resistance to airflow through the airways.
  • the device of the present invention may also be used for eliminating the smooth muscle altogether by thermally damaging or destroying it. The elimination of the smooth muscle prevents the hyper-reactive airways of an asthma patient from contracting or spasming, reducing or eliminating this asthma symptom.
  • the ability of the airway to contract can also be altered by treatment of the smooth muscle in particular patterns.
  • the smooth muscle is arranged around the airways in a generally helical pattern with pitch angles ranging from about ⁇ 30 to about +30 degrees.
  • the treatment of the smooth muscle by energy which is selectively delivered in an appropriate pattern interrupts or cuts through the helical pattern at a proper pitch and prevents the airway from constricting.
  • This procedure of patterned application of energy eliminates contraction of the airways without completely eradicating smooth muscle and other airway tissue.
  • a pattern for treatment may be chosen from a variety of patterns including longitudinal or axial stripes, circumferential bands, helical stripes, and the like as well as spot patterns having rectangular, elliptical, circular or other shapes.
  • the size, number, and spacing of the treatment bands, stripes, or spots are chosen to provide a desired clinical effect of reduced airway responsiveness while limiting insult to the airway to a clinically acceptable level.
  • the patterned treatment of the tissues surrounding the airways with energy provides various advantages.
  • the careful selection of the portion of the airway to be treated allows desired results to be achieved while reducing the total healing load.
  • Patterned treatment can also achieve desired results with decreased morbidity, preservation of epithelium, and preservation of a continuous or near continuous ciliated inner surface of the airway for mucociliary clearance.
  • the pattern of treatment may also be chosen to achieve desired results while limiting total treatment area and/or the number of airways treated, thereby improving speed and ease of treatment.
  • Application of energy to the tissue surrounding the airways also may be used to cause the DNA of the cells to become cross linked.
  • the treated cells with cross linked DNA are incapable of replicating. Accordingly, over time, as the smooth muscle cells die, the total thickness of smooth muscle decreases because of the inability of the cells to replicate.
  • the programmed cell death causing a reduction in the volume of tissue is called apoptosis.
  • This treatment does not cause an immediate effect but causes shrinking of the smooth muscle and opening of the airway over time and substantially prevents re-growth.
  • the application of energy to the walls of the airway may also be used to cause a cross linking of the DNA of the mucus gland cells thereby preventing them from replicating and reducing excess mucus plugging or production over time.
  • the ability of the airways to contract may also be reduced by altering mechanical properties of the airway wall, such as by increasing stiffness of the wall or by increasing parenchymal tethering of the airway wall. Both of these methods increase the strength of the airway wall and opposes contraction and narrowing of the airway.
  • One way to increase stiffness is to induce fibrosis or wound healing response by causing trauma to the airway wall.
  • the trauma can be caused by delivery of therapeutic energy to the tissue in the airway wall or by mechanical insult to the tissue.
  • the energy is preferably delivered in such a way that it minimizes or limits the intra-luminal thickening that can occur.
  • Another way to increase the effective stiffness of the airway wall is by altering the submucosal folding of the airway upon narrowing.
  • the submucosal layer is directly beneath the epithelium and its basement membrane and inside the airway smooth muscle.
  • the mucosal folds mechanically interfere with each other, effectively stiffening the airway.
  • the number of folds is fewer and the size of the folds is larger, and thus, the airway is free to narrow with less mechanical interference of mucosal folds than in a healthy patient.
  • asthmatic patients have a decrease in airway stiffness and the airways have less resistance to narrowing.
  • the mucosal folding in asthmatic patients can be improved by treatment of the airway in a manner which encourages folding.
  • a treatment will increase the number of folds and/or decrease the size of the folds in the mucosal layer.
  • treatment of the airway wall in a pattern such as longitudinal stripes can encourage greater number of smaller mucosal folds and increase airway stiffness.
  • the mucosal folding can also be increased by encouraging a greater number of smaller folds by reducing the thickness of the submucosal layer.
  • the decreased thickness of the submucosal layer may be achieved by application of energy which either reduces the number of cells in the submucosal layer or which prevents replication of the cells in the submucosal layer.
  • a thinner submucosal layer will have an increased tendency to fold and increased mechanical stiffening caused by the folds.
  • the parenchyma surrounds airways and includes the alveolus and tissue connected to and surrounding the outer portion of the airway wall.
  • the parenchyma includes the alveolus and tissue connected to and surrounding the cartilage that supports the larger airways.
  • the parenchyma provides a tissue network which connects to and helps to support the airway. Edema or accumulation of fluid in lung tissue in asthmatic patients is believed to decouple the airway from the parenchyma reducing the restraining force of the parenchyma which opposes airway constriction.
  • Application of therapeutic energy can be used to treat the parenchyma to reduce edema and/or improve parenchymal tethering.
  • the applied energy may be used to improve connection between the airway smooth muscle and submucosal layer to the surrounding cartilage, and to encourage wound healing, collagen deposition, and/or fibrosis in the tissue surrounding the airway to help support the airway and prevent airway contraction.
  • Airway diameter in asthmatic patients is reduced due to hypertrophy of the smooth muscle, chronic inflammation of the airway tissues, and general thickening of all parts of the airway wall.
  • the overall airway diameter can be increased by a variety of techniques to improve the passage of air through the airways.
  • Application of energy to the airway smooth muscle of an asthmatic patient can be used to debulk or reduce the volume of smooth muscle. This reduced volume of smooth muscle increases the airway diameter for improved air exchange.
  • the airway diameter can also be increased by reducing inflammation and edema of the tissue surrounding the airway. Inflammation and edema (accumulation of fluid) of the airway occur in an asthmatic patient due to irritation.
  • the inflammation and edema can be reduced by application of energy to stimulate wound healing and regenerate normal tissue.
  • Healing of the epithelium or sections of the epithelium experiencing ongoing denudation and renewal allows regeneration of healthy epithelium with less associated airway inflammation.
  • the less inflamed airway has an increased airway diameter both at a resting state and in constriction.
  • the wound healing can also deposit collagen which improves parenchymal tethering.
  • Inflammatory mediators released by tissue in the airway wall may serve as a stimulus for airway smooth muscle contraction. Smooth muscle contraction, inflammation, and edema can be reduced by a therapy which reduces the production and release of inflammatory mediators.
  • inflammatory mediators are cytokines, chemokines, and histamine.
  • the tissues which produce and release inflammatory mediators include airway smooth muscle, epithelium, and mast cells. Treatment of these structures with energy can reduce the ability of the airway structures to produce or release inflammatory mediators. The reduction in released inflammatory mediators will reduce chronic inflammation, thereby increasing the airway inner diameter, and may also reduce hyper-responsiveness of the airway smooth muscle.
  • a further process for increasing the airway diameter is by denervation.
  • a resting tone of smooth muscle is nerve regulated by release of catecholamines.
  • Excess mucus production and mucus plugging are common problems during both acute asthma exacerbation and in chronic asthma management.
  • Excess mucus in the airways increases the resistance to airflow through the airways by physically blocking all or part of the airway.
  • Excess mucus may also contribute to increased numbers of leukocytes found in airways of asthmatic patients by trapping leukocytes. Thus, excess mucus can increase chronic inflammation of the airways.
  • One type of asthma therapy involves treatment of the airways with energy to target and reduce the amount mucus producing cells and glands and to reduce the effectiveness of the remaining mucus producing cells and glands.
  • the treatment can eliminate all or a portion of the mucus producing cells and glands, can prevent the cells from replicating or can inhibit their ability to secrete mucus. This treatment will have both chronic benefits in increasing airflow through the airways and will lessen the severity of acute exacerbations.
  • each of the treatment devices described below can be modified to deliver or to remove energy in different patterns depending on the treatment to be performed.
  • the treatment devices may be actuated continuously for a predetermined period while stationary, may be pulsed, may be actuated multiple times as they are moved along an airway, may be operated continuously while moving the device in an airway to achieve a “painting” of the airway, or may be actuated in a combination of any of these techniques.
  • the particular energy application pattern desired can be achieved by configuring the treatment device itself or by moving the treatment device to different desired treatment locations in the airway.
  • the treatment of an airway with the treatment device may involve placing a visualization system such as an endoscope or bronchoscope into the airways.
  • the treatment device is then inserted through or next to the bronchoscope or endoscope while visualizing the airways.
  • the visualization system may be built directly into the treatment device using fiber optic imaging and lenses or a CCD and lens arranged at the distal portion of the treatment device.
  • the treatment device may also be positioned using radiographic visualization such as fluoroscopy or other external visualization means.
  • the treatment device which has been positioned with a distal end within an airway to be treated is energized so that energy is applied to the tissue of the airway walls in a desired pattern and intensity.
  • the distal end of the treatment device may be moved through the airway in a uniform painting like motion to expose the entire length of an airway to be treated to the energy.
  • the treatment device may be passed axially along the airway one or more times to achieve adequate treatment.
  • the “painting-like” motion used to exposed the entire length of an airway to the energy may be performed by moving the entire treatment device from the proximal end either manually or by motor. Alternatively, segments, stripes, rings or other treatment patterns may be used.
  • the energy is transferred to or from an airway wall in the opening region of the airway, preferably within a length of approximately two times the airway diameter or less, and to wall regions of airways distal to bifurcations and side branches, preferably within a distance of approximately twice the airway diameter or less.
  • the invention may also be used to treat long segments of un-bifurcated airway.
  • One such treatment alters the structure of the airway, such as by reducing the amount of airway tissue.
  • the addition of energy to the airway tissue may cause the DNA of the muscle cells to become cross linked.
  • the smooth muscle cells with cross linked DNA cannot replicate.
  • Another treatment alters the function of the airway, such as by reducing smooth muscle contraction, mucus gland secretions, or disrupting the inflammatory response.
  • These treatments can be performed by applying energy of different types and in different patterns to achieve the desired results. In such cases, stiffness of the airway is increased as the energy induces a fibrosis or wound healing response that causes trauma to the airway wall.
  • FIGS. 1 and 2 illustrate cross sections of two different airways in a healthy patient.
  • the airway of FIG. 1 is a medium sized bronchus having an airway diameter D 1 of about 3 mm.
  • FIG. 2 shows a section through a bronchiole having an airway diameter D 2 of about 1.5 mm.
  • Each airway includes a folded inner surface or epithelium 10 surrounded by stroma 12 and smooth muscle tissue 14 .
  • the larger airways including the bronchus shown in FIG. 1 also have mucous glands 16 and cartilage 18 surrounding the smooth muscle tissue 14 . Nerve fibers 20 and blood vessels 22 also surround the airway.
  • FIG. 3 illustrates the bronchus of FIG. 1 in which the smooth muscle 14 has hypertrophied and increased in thickness causing the airway diameter to be reduced from the diameter D 1 to a diameter D 3 .
  • FIG. 4 is a schematic side view of the lungs being treated with an energy transferring apparatus 30 according to the present invention.
  • the device 30 is an elongated member for facilitating exchanging energy with a mass of airway tissue at a treatment site 34 within the lungs.
  • the device 30 must be of a size to access the bronchus or bronchioles of the human lung.
  • the device may be sized to fit within bronchoscopes, preferably, with bronchoscopes having a working channel of 2 mm or less. Also, the device should be of sufficient stiffness to fit and operate through the seal covering the working channel a bronchoscope.
  • the energy may be delivered by the treatment device 30 in a variety of treatment patterns to achieve a desired response. Examples of patterns are discussed in further detail below.
  • the energy which is delivered by the treatment device 30 may be any of a variety of types of energy including, but not limited to, radiant, laser, radio frequency, microwave, heat energy, or mechanical energy (such as in the form of cutting or mechanical dilation).
  • the device may, but is not necessarily, configured to deliver energy in non-intersecting strip patterns which are parallel with a central axis of an airway.
  • the device may be configured to deliver energy in a torsional pattern, or in a circumferential pattern around a wall of the airway.
  • Such configurations which may be determined to deliver energy to the airway tissue that maximize the ability of the airway to permit airflow are considered to be within the scope of this invention.
  • the inventive devices include tissue contacting electrodes configured to be placed within the airway. These devices can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated elements.
  • tissue contacting electrodes configured to be placed within the airway. These devices can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated elements.
  • monopolar energy delivery one or more electrodes of the treatment device are connected to a single pole of the energy source 32 and an optional external electrode 44 is connected to an opposite pole of the energy source.
  • bipolar energy delivery multiple electrodes are connected to opposite poles of the energy source 32 and the external electrode 44 is omitted.
  • the external electrode 44 depicted in FIG. 4 is not required in the case of bipolar energy delivery.
  • the number and arrangement of the electrodes may vary depending on the pattern of energy delivery desired.
  • the treatment devices of FIGS. 5A-10 , and 12 - 20 are used to deliver radiant or heat energy to the airway.
  • the treatment device of FIG. 11 may also be used to deliver indirect radio frequency, microwave energy, or conductive heat energy to the tissue.
  • the current may be AC or DC current or in the case of AC, the current may be delivered in the RF range.
  • the use of RF provides an added safety feature of minimizing the possibility of harm to the patient caused by escaped current.
  • the device may also use a combination of any of the energy transferring element configurations described herein.
  • the treatment device 302 of FIG. 5A includes an elongated member 102 for delivering an expandable member 104 to a treatment site.
  • the expandable member 104 may have a plurality of energy transfer elements (not illustrated) which are placed on a plurality of basket legs 106 to transfer energy at the treatment site.
  • the expandable member comprises a basket 104 which is defined by a number of basket legs 106 .
  • the basket legs 106 are formed from a plurality of elements which are soldered or otherwise connected together at two connection areas, a proximal joint 108 and a distal joint 110 .
  • a desirable length of the basket 104 depends upon numerous factors.
  • One consideration in determining a desired length of the expandable member, e.g., the distance between the joints of the basket, of the inventive device is related to the dimension of the target area or treatment region. For instance, some other factors include considerations of minimizing the amount of the expandable portion which is distal to the treatment region for optimized access, minimizing the amount of the expandable portion that is proximal to the treatment region for visualization and access concerns, and setting a desirable length of the expandable portion that will contact a sufficient portion of the treatment region during each application of the device.
  • a compromise of such factors along with other considerations provides a desirable length for the expandable portion of the device.
  • the distance between the distal and proximal joints of the basket is less than 35 mm when the basket is in a first unexpanded state.
  • the legs 106 may be selected from a material that allows the basket to expand without plastic deformation.
  • the legs may comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material.
  • the basket legs 106 may have a rectangular cross section in those variations where the legs 106 are formed from ribbons, or the legs 106 may have a circular cross section in those variations where the legs are formed from wires.
  • the legs 106 may also have other cross section as desired. It is also contemplated that the legs 106 need not all have similar cross sections.
  • the cross section of each of the legs 106 in a basket 104 may be individually chosen to optimize such factors as the resilience of the basket 104 , or to optimize energy transfer characteristics.
  • the legs may also have a variable cross section along the length of the basket.
  • the proximal 108 and/or distal 110 joints may also contain adhesive to bind the legs 106 .
  • the basket legs 106 between the proximal 108 and distal joint 110 are formed into the basket shape 104 so that arch shaped portions of the basket legs 106 will contact the walls of an airway to facilitate energy transfer.
  • the basket legs 106 may have a more oblong shape or sharper bends to allow for a more parallel leg surface area that contacts the target tissue.
  • Each leg 106 may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg 106 . The center that is substantially parallel is usually referred to as the active region of the leg 106 .
  • the length of the basket 104 between the proximal and distal 110 joints may be less than 35 mm when the basket 104 is in a first unexpanded state.
  • the legs 106 may be coated with an insulating material (not shown) except at the tissue contact points.
  • the legs 106 of the basket 104 may be exposed while the proximal 108 and distal joint 110 are insulated.
  • the basket 104 is formed of a resilient material which allows the distal end of the inventive device 302 to be confined by a sheath (not shown) for delivery of the device 302 to the treatment site and allows the basket 104 to return to its original basket shape upon deployment.
  • a variation of the invention is that the basket self-expands from a first state to a second expanded state upon the removal of any constraining or restrictive member such as a sheath (not shown).
  • the inventive device 302 is preferably configured such that the basket legs 106 have sufficient resilience to come into contact with the airway walls for treatment.
  • FIG. 5A further illustrates a variation of the inventive device 302 in which a distal end of the device 302 is provided with a distal tip 112 that can have a radius to facilitate insertion of the device 302 into the lungs and also to minimize the possibility of causing trauma to surrounding tissue.
  • the tip 112 is preferably sized to prevent the gouging of airway by the sheath.
  • the design of the distal tip is selected to be atraumatic.
  • the size of the tip may be selected to be large enough to prevent the sheath from gouging airways yet small enough to pass in and out of a bronchoscope.
  • FIG. 5B illustrates a variation of the inventive device 302 having basket legs 108 connected to a distal end 114 of the elongated member 102 and forming a basket 104 .
  • a proximal joint is found at the distal end 114 of the elongated member 102 .
  • the basket 104 is expanded radially, to its second state, during use to ensure contact between the energy transfer elements (not shown) and the airway walls (not shown) by, for example, pulling on a center pull wire 116 which is connected to a distal tip 118 of the expandable portion 104 .
  • the center pull wire 116 may extend through a lumen of the elongated member 102 towards a proximal portion (not shown) of the elongated member 102 . It is also contemplated that the center pull wire 116 may be configured to deliver current to the energy transfer elements found on the expandable member 104 .
  • the inventive device 302 may be delivered to a treatment site through a delivery sheath 120 and may be drawn along or moved axially along the airway to treat the airway in a pattern of longitudinal or helical stripes.
  • the basket 104 may be resilient or self-expanding (e.g., see FIG. 5A ) to expand to a second expanded state or the basket 104 may require an expanding force (e.g., see FIG. 5B ).
  • FIG. 5B An example of this variation of the inventive device 304 is shown in FIG. 5B .
  • the basket 104 may be resilient and the sheath 120 may comprise the deployment member.
  • the basket 104 contracts within the sheath 120 and assumes a first state.
  • the basket 104 may resiliently assume a second expanded state.
  • the basket 104 may assume a second expanded state with the aid of a wire 116 .
  • This wire may also be configured to deliver power to the energy exchange elements 106 .
  • FIG. 5C illustrates another variation of the inventive device where an elongated member 102 of is configured to have a plurality of lumens 140 so that each of the basket legs 106 are isolated within the lumens 140 of the elongated member 102 until the legs 106 exit the elongated member 102 and connect at a proximal joint 108 .
  • the invention may have basket legs 106 selected with a sufficient length such that the ends of each of the legs 106 extend substantially into the lumens 140 . As a result of being inserted deeply within the lumen, the ends of the legs 106 would require significant travel before they exited the lumen 140 . This feature provides added safety as it minimizes the risk of the basket legs 106 dislodging from the elongate member 102 .
  • the elongated member 102 may comprise concentric tubes (not shown) rather than multi-lumen tubes where basket legs are inserted in the annulus between the tubes. It is also contemplated that an elongated member may be reinforced with the use of a reinforcing member. Such a reinforcing member may include a coiled wire or polymeric insert.
  • FIG. 5D-5I illustrate variations of the inventive device that use an expanding force to expand the basket.
  • FIG. 5D illustrates a deployment member of the device.
  • FIG. 5E illustrates the device of FIG. 5D when the elongated member is moved in a distal direction to a deployment point.
  • FIG. 5F-5G illustrates the elongated member 102 , sheath 120 , expandable member 104 , distal tip 118 , and wire 122 extending through the device.
  • FIG. 5F illustrates the basket 104 in a first unexpanded state when the elongated member 102 and wire 122 are proximal of the deployment point 130 .
  • FIG. 5G illustrates the expansion of the basket 104 to a second expanded state as the elongated member 102 moves distally and the wire 122 is restrained at the deployment point 130 .
  • the deployment member may comprise a handle 124 which is adjacent to a proximal portion of an elongated member 102 .
  • the handle may be designed to be operated by a single hand, either right or left.
  • the handle may also have a control switch for operation of the device. Such a switch could control the power supply attached to the device as well.
  • the handle may be configured to determine the position of the device within a human body as the device is advanced to a target site. For example, marks on the handle or even a readout could provide information to the user as to the relative deployment state of the expandable member.
  • a sensor may be placed on the handle 124 , this sensor may be used to determine the position of the expandable member.
  • the handle 124 may control the expandable member using force compensation (e.g., a spring, etc.) or deflection limiting stops to control the expansion of the expandable member.
  • force compensation e.g., a spring, etc.
  • deflection limiting stops to control the expansion of the expandable member.
  • an elongated member 102 may be slidably mounted to the handle.
  • the variation of the invention depicted in these Figures may also, but does not necessarily, include a sheath 120 exterior to the elongated body 102 .
  • a wire 122 extends from the handle through the elongated member 102 and may be attached to a distal tip 118 of the device.
  • the wire 122 , elongated member 102 , and distal tip (not shown) are slidably moveable in both a distal and proximal directions.
  • the handle may also include a stop 126 which prevents the wire 122 from moving distally beyond a deployment point 130 .
  • the stop 126 may be connected to a spring (not shown) to limit the expansion of the expandable member upon reaching a pre-determined force.
  • the handle 124 may include a control member 128 that is moveably attached to the handle 124 for moving the elongated member 102 in a distal/proximal direction.
  • the handle 124 in the figures is depicted to have a control member 128 as illustrated, other variations of control members are also contemplated to be within the scope of this invention.
  • a handle 124 may include other configurations, such as lever, thumb-wheel, screw-mechanism, ratchet mechanism, etc., which are attached to the handle 124 to provide control actuation for the expandable member.
  • FIG. 5E illustrates a variation of the inventive device when the elongated member 102 and wire 122 are moved in a distal direction.
  • a stop 126 prevents the wire 122 from moving distally of a deployment position 130 .
  • This illustration further illustrates a variation of the invention where the stop 126 is attached to springs 127 which provide force compensation for the expandable member on the device.
  • a control member 128 may have a stop which limits its travel along a handle 124 . Such a stop is an example of a deflection limiting mechanism which controls the movement of the control member 128 , thus controlling the extent of the expansion of the expandable member.
  • FIG. 5F illustrates the invention when the expandable member or basket 104 is in a first unexpanded state.
  • the wire 122 is attached to a distal tip 118 of the device and both are prevented from distal movement when the wire 122 is in the deployment position 130 . Therefore, as depicted in FIG. 5G , movement of the elongated member 102 in a distal direction against a distal tip 118 , that is restrained by a wire 122 , causes a basket 104 to compress between the advancing elongated member 102 and the stationary distal end 118 . Thus, the basket 104 is forced outward and radially expands into a second expanded state.
  • the wire 122 may also be used to transfer energy to or from the energy transfer elements found on the basket 104 .
  • the wire 122 may be a wire, a ribbon, a tube, or of any other equivalent structure.
  • a detent means for maintaining the elongated member in a distal position to expand the basket 104 against the distal tip 118 without the need for continual applied force by a user of the device.
  • a ratchet member, or friction member to maintain the basket 104 in the expanded state.
  • FIG. 5H illustrates another variation of a deployment member.
  • a sheath 120 may be slidably attached to a handle 124 .
  • the elongate member 102 is rigidly attached to the handle 124 .
  • the sheath 120 may be attached to a first control member 129 .
  • a wire 122 extends through the elongate member 102 and is attached to the distal tip of the device (not shown).
  • the wire 122 may be attached to a second control member 131 .
  • proximal movement of the first control member 129 causes the sheath 120 to proximally retract over the elongate member 102 and uncover the expandable portion (not shown).
  • Proximal movement of the second control member 131 causes the wire 122 , distal joint, and expandable member to move against the non-moving elongate member 102 which causes the expandable member to expand into a second state.
  • FIG. 5J-5L illustrate examples of energy transfer elements that may be located on the expandable portion of the device.
  • the basket legs 106 may function as heat exchange elements.
  • the device may be configured so that the leg is an electrode or the conductive heating element.
  • the leg 106 may be partially covered with an insulation only leaving an active region exposed for delivery of energy to the airways. Examples of such insulation include a heat shrink sleeve, a dielectric polymeric coating, or other material which may function as an insulator.
  • FIG. 5J illustrates an example of a basket leg 106 with an energy transferring element 132 coiled around the leg 106 .
  • the energy transferring element uses conductive heating and comprises a resistance heating element 132 coiled around the leg 106 .
  • FIG. 5K illustrates a variation of the invention having an RF electrode attached to the basket leg 106 .
  • the RF electrode may be attached to the basket leg 106 via the use of a fastener 134 .
  • the electrode may be attached via the use of a heat shrink fastener 134 , (e.g., polymeric material such as PET or polyethylene tubing).
  • FIG. 5L illustrates another variation of the invention where the energy transfer element is a printed circuit 138 that is situated around the leg 106 and secured to the leg.
  • energy transfer elements are a polymeric heating material, an electrically conductive paint, a resistance element sputtered onto the leg in a pattern or formed on a substrate by photofabrication.
  • the basket leg itself may be chosen of appropriate size and resistivity to alloy dual use as a basket and energy transfer element. Many nickel-chromium alloys have both high specific resistance and significant spring-like properties.
  • adhesives or other coatings may also be used to secure the energy transfer element to the basket leg 106 .
  • the energy transfer elements are not limited to what is illustrated in the drawings. It is also contemplated that other types of energy transferelements may be used such as radiant, laser, microwave, and heat energy.
  • FIG. 6A illustrates a variation of a distal tip 210 having a redundant joint.
  • the distal tip 208 has a polymeric cap 210 covering the distal ends of the basket legs 106 and wire 212 .
  • the legs 106 are soldered 214 to the distal end of the wire 212 .
  • Also used to maintain the joint is an adhesive 216 substantially filling the polymeric cap 210 .
  • a multi-lumen piece 218 separates the legs 106 and wire 212 .
  • a side view of the multi-lumen piece 218 is shown in FIG. 6B .
  • a multi-lumen tubing may be used for the multi-lumen piece 218 .
  • the ends 220 of the polymeric cap 210 may be heat formed or otherwise tapered down around the legs 106 .
  • FIG. 6C illustrates another variation of a distal tip 222 having a redundant joint.
  • the distal tip 222 has a polymeric cap 210 covering the distal ends of the basket legs 106 and wire 212 .
  • the legs 106 are soldered 214 to the distal end of the wire 212 .
  • Also used to maintain the joint is an adhesive 216 substantially filling the polymeric cap 210 .
  • a hypo-tube 224 covers the legs 106 and wire 212 .
  • a side view of the hypo-tube 224 is shown in FIG. 6D .
  • the distal end of the hypo-tube 224 may be flared to seat a ball located on a distal end of the wire 212 and the legs 106 .
  • a proximal end of the hypo-tube 224 may be flared to provide greater interlock with ends 220 of the polymeric cap 210 .
  • the ends of the legs 106 taper outwards from the hypo-tube 224 and form an area with a diameter larger than the end of the cap 226 which may be tapered down around the legs 106 and wire 212 .
  • the ends 220 of the polymeric cap 210 may be heat formed or otherwise tapered down.
  • FIG. 6E shows another variation of the invention having a hoop or ring 228 at a proximal joint of the device.
  • the hoop 228 may be soldered or welded to the legs 106 and keeps the legs 106 attached even if a joint fails between the legs and the elongate member 102 . Also, the hoop 228 may electrically connect the legs, preventing disconnection of single leg 106 having a temperature sensing element attached.
  • the invention also includes a temperature detecting element (not shown).
  • temperature detecting elements include thermocouples, infrared sensors, thermistors, resistance temperature detectors (RTDs), or any other apparatus capable of detecting temperatures or changes in temperature.
  • the temperature detecting element is preferably placed in proximity to the expandable member.
  • a temperature sensor may be mounted along the pull wire 116 .
  • a temperature sensor may be mounted between the energy transfer elements 132 , 136 , 138 and the leg 106 .
  • a temperature sensor is placed on a single basket leg 106 to provide a signal to control energy transfer.
  • a temperature sensor may be placed on more than one basket leg 106 , and/or on a central wire 116 to provide control for multiple areas of energy transfer.
  • the temperature sensor may be placed on the inside of the basket leg 106 to protect the temperature sensor while still providing a position advantageous to determining the device temperature at the energy transfer element.
  • FIG. 5M illustrates a variation of the invention having thermocouple leads 139 attached to a leg 106 of the device.
  • the leads may be soldered, welded, or otherwise attached to the leg 106 .
  • This variation of the invention shows both leads 139 of the thermocouple 137 attached in electrical communication to a leg 106 at separate joints 141 .
  • the temperature sensor is at the surface of the leg.
  • This variation provides in case either joint becomes detached, the circuit will be open and the thermocouple 137 stops reading temperature.
  • the device may also include both of the thermocouple leads as having the same joint.
  • FIG. 7A-7D illustrate variations of the device in which impedance may be varied by wiring the basket legs 106 in series or in parallel.
  • FIG. 7A illustrates a series wiring diagram in which a current path 142 flows from a first leg to a second leg 106 , a third leg 106 , and a fourth leg 106 sequentially.
  • FIG. 7B illustrates the series wiring diagram and shows a single wire 143 connecting the legs 106 in series.
  • the wire 143 may, for example, extend to a distal end of the leg and wrap over itself to the proximal end of the leg 106 .
  • a covering (not shown) may be placed over the wire 143 wrapped leg 106 at the proximal end of the device.
  • FIG. 7C illustrates another variation of a series wiring diagram.
  • a wire 143 extends from the proximal end of a leg 106 to its distal end and then extends to the distal end of an adjacent leg 106 and extends back to the proximal end
  • FIG. 7D illustrates a parallel wiring diagram in which a current path 142 flows to each leg 106 .
  • Series wiring has an added advantage in that all current will pass through each energy transfer element. By design, this configuration equalizes the heat dissipated at each leg through construction of legs with equal resistance. In addition, in the event of failure of any electrical connection, no energy is delivered. This provides an additional safety feature over parallel wiring.
  • the electrical current may be AC or DC.
  • AC may be delivered in the RF range as a safety measure additional to electrical isolation.
  • DC may be used to allow a portable device powered by a battery pack or provide an energy source within the device itself.
  • FIG. 8A-8C illustrates variation of the legs 106 of the basket 104 .
  • the legs may, for example, comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material.
  • the basket legs 106 may have a rectangular cross section in those variations where the legs 106 are formed from ribbons, or the legs 106 may have a circular cross section in variations where the legs 106 are formed from wires.
  • a leg 106 may be configured to have a non-axisymmetric cross-section. For example, the leg may have an oval or flat cross section as well.
  • the legs 106 of a basket 104 need not all have similar cross sections.
  • each of the legs 106 in a basket 104 may be individually chosen to optimize such factors as the resilience of the basket 104 , or to optimize energy transfer characteristics.
  • FIG. 8A illustrates a top view of a basket leg 106 that has a contoured shape 144 .
  • the energy exchange element is not shown in the figure for clarity.
  • FIG. 8B One of the purposes of such a contoured shape 144 is illustrated in FIG. 8B .
  • leg 106 is configured to bend at or substantially near to points 146 .
  • a benefit of such a configuration is to allow a substantially parallel active surface as defined by the contour shape 144 .
  • the leg 106 has a region of increased diameter 148 in the case of round wire, or increased width or thickness in the case of rectangular or other non-axisymmetric wire.
  • a region 106 could also be a flat wire with bumps or protrusions creating areas of increased width of the flat wire.
  • This region 148 may, for example, provide a stop that assists in locating insulation, heat shrink, or other external covering around the leg 106 .
  • a leg 106 that consists of a composite construction.
  • the leg 106 may comprise of differing materials in predetermined regions to control the bending of the leg 106 as the basket 104 expands, or the leg may be constructed of different materials to selectively control regions of deliver of energy on the leg.
  • FIG. 9A-9D illustrates another variation of the inventive device in which the expandable member comprises basket from a single piece or sheet of material. Such a configuration could comprise an etched, machined, laser cut, or otherwise manufactured piece of metal.
  • FIG. 9A illustrates a partial view of a basket 104 formed from a single piece of material. The thickness of the material is, for example 0.005 inches but may vary as desired.
  • the illustration of FIG. 9A shows the basket 104 prior to being wrapped about the Z direction as indicated. As shown, the legs 106 may be of varying length or they may be the same length 106 or a combination thereof.
  • the basket 104 may have a distal portion 164 or basket head 164 which may be configured to facilitate construction of the device.
  • the basket head 164 may be notched 166 to obtain a desired shape as the basket is wrapped about the Z direction.
  • FIG. 9B illustrates a variation of the basket head 165 being notched such that sections 165 of the material may be bent from the plane of the material to form tabs 165 .
  • Tabs 165 may be used to form mechanical joints with another part, such as a distal tip cap.
  • FIG. 9C illustrates another variation of a basket 104 made from a single piece of material.
  • the legs 106 of the basket 104 are bent in a direction orthogonal to the plane of the basket head 164 .
  • the distance between the ends of the legs 106 may be, for example, about 2.75 inches.
  • FIG. 9D illustrates a variation of the proximal ends of the legs 106 of the basket 104 .
  • the proximal ends of the legs 106 may have features 168 which promote the structural integrity of the proximal joint (not shown) of the device.
  • the ends of the legs 106 have a saw-tooth design which improve the integrity of the proximal joint connecting the legs 106 to the elongated member.
  • the variation of FIG. 9D also illustrates a proximal end of the leg 106 as having a radius, however, the end of the leg 106 may have other configurations as required.
  • the legs 106 may have a width of, for example, 0.012 inches and a separation of, for example, 0.016 inches. However, these dimensions may vary as needed.
  • FIG. 10 illustrates another variation of the inventive device 306 in which the expandable member comprises a balloon member 150 .
  • This variation of the device 306 includes electrodes 154 positioned on an exterior surface of the balloon member 150 .
  • the electrodes 154 may be connected to an energy source (not shown) by leads 156 extending through the balloon and through the lumen of an elongated member 102 .
  • the balloon member 150 may be filled with a fluid 152 such as saline or air to bring the electrodes 154 into contact with the airway wall 10 .
  • the electrodes may also be resistance heating elements, RF electrodes, or another suitable element for conducting energy transfer with the airway.
  • a single electrode may continuously surround a circumference of a balloon 150 , or a plurality of electrodes may be spaced at certain intervals to substantially surround the circumference of a balloon 150 .
  • FIG. 11 illustrates another variation of the inventive device 308 in which the expandable member comprises a balloon member 150 in which a fluid 152 within the balloon member 150 is heated by a heat generating element 158 .
  • the heat generating elements 158 are illustrated in the shape of coils surrounding the shaft of the elongated member 102 , however other types of heat generating elements (not shown) shapes may also be used.
  • the heat generating elements 154 may be used as resistance heaters by application of an electric current to the heat generating elements. Alternatively, radio frequency or microwave energy may be applied to the heat generating elements 158 to heat fluid 152 within the balloon member 150 .
  • the fluid may be configured to optimize conductive heat transfer from the electrodes 158 to the exterior of the balloon member 150 .
  • Radio frequency or microwave energy may also be applied indirectly to the airway wall through the fluid and the balloon.
  • hot fluid may be transmitted to the balloon member 150 from an external heating device for conductive heating of the airway tissue.
  • FIG. 12 Another variation of the inventive device 310 is illustrated in FIG. 12 includes a plurality of energy transfer elements 162 positioned on pre-shaped tines 160 .
  • the pre-shaped tines 160 may be outwardly biased such that they expand from a first shape inside sheath 120 into a second expanded shape once advanced out of sheath 120 .
  • the tines 160 may also be configured so that they retract into a first state once withdrawn into a sheath 120 .
  • the pre-shaped tines 160 may be connected to an elongate member 102 which is positioned within a sheath 120 .
  • the pre-shaped tines 160 and the energy transfer elements 162 may be delivered through a delivery sheath 120 to a treatment site within the airways. When the pre-shaped tines 160 exit a distal end of the sheath 120 , the pre-shaped tines 160 may bend outward until the energy transfer elements 162 come into contact with the airway walls for transfer of energy with the airway walls.
  • FIG. 13 illustrates a variation of the inventive device 314 in which a elongated member 102 is provided with a plurality of energy transfer elements 170 positioned on at least one inflatable balloon 172 .
  • the energy transfer elements 170 may be RF electrodes or resistance heating elements.
  • the balloons 172 are inflated through the elongated member 102 to cause the energy transfer elements 170 to come into contact with the airway walls 10 .
  • the energy transfer elements 170 are preferably connected to the energy source (not shown) by conductive wires (not shown) which extend from the energy transfer elements 170 through or along the balloons 172 and through the elongated member 102 to the energy source.
  • the electrodes 170 may be used in a bipolar mode without an external electrode.
  • the inventive device 314 may be operated in a monopolar mode with an external electrode (not shown, see FIG. 4 ).
  • Another variation of the invention includes using resistance heating elements as the energy transfer elements 170 .
  • the energy transfer elements 170 may be a single continuous circular element or there may be a plurality of elements 170 spaced around the balloons 172 .
  • An alternative of the inventive device 316 of FIG. 14 includes an elongated member 102 having one or more grooves 174 in an exterior surface. Positioned within the grooves 174 are electrodes 176 for delivery of energy to the airway walls. Although the grooves 174 have been illustrated in a longitudinal pattern, the grooves may be easily configured in any desired pattern.
  • the inventive device 316 of FIG. 14 includes a biasing member (not shown) for biasing the elongated member 102 against an airway wall such that the electrodes 176 contact airway tissue.
  • the biasing member may be a spring element, an inflatable balloon element, or other biasing member.
  • the biasing function may be performed by providing a preformed curve in the elongated member 102 which causes the device to curve into contact with the airway wall when extended from a delivery sheath (not shown).
  • FIG. 15 illustrates a variation of the inventive device 318 having one or more electrodes 178 connected to a distal end of an elongated tube 102 .
  • the electrodes 178 are supported between the distal end of the elongated tube 102 and a distal tip 180 .
  • a connecting shaft 182 supports the tip 180 .
  • Also connected between the distal end of the elongated member 102 and the distal tip 180 is a spring element 184 for biasing the electrodes 178 against a wall of the airway.
  • the spring element 184 may have one end which slides in a track or groove in the elongated member 102 such that the spring 184 can flex to a variety of different positions depending on an internal diameter of the airway to be treated.
  • FIG. 16 illustrates an alternative of the inventive device 320 in which the one or more electrodes 186 are positioned on a body 188 secured to an end of an elongated member 102 .
  • the body 188 is illustrated as egg shaped, however, other body shapes may also be used.
  • the electrodes 186 extend through holes 190 in the body 188 and along the body surface.
  • a biasing member such as a spring element 184 is preferably provided on the body 188 for biasing the body with the electrodes 186 against the airway walls.
  • Leads 192 are connected to the electrodes 186 and extend through the elongated member 102 to the energy source not shown.
  • FIGS. 17 and 18 illustrate embodiments of the invention 322 , 324 in which electrodes 194 in the form of wires are positioned in one or more lumens 196 of an elongated member 102 . Openings 198 are formed in side walls of the elongated member 102 to expose the electrodes 194 to the surrounding tissue.
  • the inventive device 322 may have multiple lumens 196 with electrodes 194 provided in each of the lumens 196 .
  • the side wall of the inventive device 322 is cut away to expose one or more of the electrodes 194 through a side wall opening 198 .
  • the opening 198 exposes two electrodes 194 positioned in adjacent lumens.
  • the inventive device 322 may be provided with a biasing member as discussed above to bring the electrodes 195 of the device into contact with the airway wall.
  • FIG. 18 Another variation of the inventive device 324 as shown in FIG. 18 includes an elongated member 102 which has an expandable loop shaped member 202 to allow the electrodes 194 to be exposed on opposite sides of the device 324 which contacts opposite sides of the airway.
  • the resilience of the loop shaped member 202 causes the electrodes 194 to come into contact with the airway walls.
  • FIGS. 19 and 20 illustrate a further variation of the inventive device 326 having an expandable member 204 in a first non-expanded state and in a second expanded state.
  • FIG. 19 illustrates the device as having one or more loop shaped electrodes 204 connected to an elongated member 102 .
  • the loop of the electrode 204 lies along the sides of a central core 206 .
  • a distal tip of the loop electrode 204 is secured to the core 206 and to a distal tip 208 .
  • the core 206 may be slidable in a lumen of the elongated member 102 .
  • the electrode 204 is expanded by pulling the core 206 proximally with respect to the elongated member 102 , as shown in FIG. 20 .
  • the electrode 204 or the core 206 may be spring biased to return to a configuration of FIG. 20 when a constraining force is removed. This constraining force may be applied by a delivery sheath or bronchoscope through which the inventive device 326 is inserted or by a releasable catch.
  • the treatment of the tissue in the airway walls by transfer of energy according to the present invention provides improved long term relief from asthma symptoms for some asthma sufferers.
  • some amount of smooth muscle or mucus gland cells which were not affected by an initial treatment may regenerate and treatment may have to be repeated after a period of time such as one or more months or years.
  • the airways which are treated with the device according to the present invention are preferably 1 mm in diameter or greater, more preferably 3 mm in diameter.
  • the devices are preferably used to treat airways of the second to eighth generation, more preferably airways of the second to sixth generation.
  • the present invention has been described in detail with respect to devices for the treatment of airways in the lungs, it should be understood that the present invention may also be used for treatment of other body conduits.
  • the treatment system may be used for reducing smooth muscle and spasms of the esophagus of patients with achalasia or esophageal spasm, in coronary arteries of patients with Printzmetal's angina variant, for ureteral spasm, for urethral spasm, and irritable bowel disorders.
  • the devices and method describe herein provide a more effective and/or permanent treatment for asthma than the currently used bronchodilating drugs, drugs for reducing mucus secretion, and drugs for decreasing inflammation.
  • the inventive device may also include a steering member configured to guide the device to a desired target location.
  • this steering member may deflect a distal tip of the device in a desired direction to navigate to a desired bronchi or bronchiole.
  • a vision system may comprise a fiber optic cable which allows a user of the device to guide a distal tip of the device to its desired location.
  • the vision system may include a CCD chip.
  • a power supply for providing energy as described above.
  • the power supply provides the energy to be delivered to airway tissue via the energy transfer device. While the main goal of the power supply is to deliver enough energy to produce the desired effect, the power supply must also deliver the energy for a sufficient duration such that the effect persists. This is accomplished by a time setting which may be entered into the power supply memory by a user.
  • a power supply may also include circuitry for monitoring parameters of energy transfer: (for example, voltage, current, power, impedance, as well as temperature from the temperature sensing element), and use this information to control the amount of energy delivered.
  • parameters of energy transfer for example, voltage, current, power, impedance, as well as temperature from the temperature sensing element
  • a power supply may also include control modes for delivering energy safely and effectively. Energy may be delivered in open loop power control mode for a specific time duration. Energy may also be delivered in temperature control mode, with output power varied to maintain a certain temperature for a specific time duration. In the case of RF energy delivery via RF electrodes, the power supply may operate in impedance control mode.
  • the power supply will operate at up to a 75° C. setting.
  • the duration must be long enough to produce the desired effect, but as short as possible to allow treatment of all of the desired target airways within a lung. For example, 5 to 10 seconds per activation (while the device is stationary) is preferred. Shorter duration with higher temperature will also produce acceptable acute effect.
  • the power supply may include control algorithms to limit excessive thermal damage to the airway tissue. For example, in order to stop delivery of energy in the event of contact between airway tissue and device legs having temperature sensing capabilities, an algorithm may be employed to shut down energy delivery if the sensed temperature does not rise by a certain number of degrees in a pre-specified amount of time after energy delivery begins.
  • Another way to stop energy delivery includes shutting down a power supply if the temperature ramp is not within a predefined rage at any time during energy delivery.
  • Other algorithms include shutting down a power supply if a maximum temperature setting is exceeded or shutting down a power supply if the sensed temperature suddenly changes, such a change includes either a drop or rise, this change may indicate failure of the temperature sensing element.
  • a variation of the invention includes configuring each energy exchange element independently to provide selective energy transfer radially about the device.
  • another variation of the invention includes providing feedback control to determine the impedance of the airway to determine the power required by a power supply. Again, as discussed above, the feedback control could also be used to determine the size of the airway in which the device is positioned.

Abstract

This relates to a device for treating lung disease, and more particularly, relates to a device for exchanging energy with airway tissue such as that found in the airways of human lungs. The exchange of energy with this airway tissue in the airways reduces the ability of the airways to constrict and/or reduces the resistance within the airway to the flow of air through the airway.

Description

  • This is a Continuation-in-part application of U.S. application Ser. No. 09/296,040 filed Apr. 21, 1999, and of Continuation-in-part U.S. application Ser. No. 09/095,323 filed Jun. 10, 1998 both of which applications are incorporated herein by reference in their entirety.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The invention relates to a device for treating lung disease, and more particularly, the invention relates to a device for transferring energy into airway tissue such as that found in the airways of human lungs. This includes heating and applying RF energy to the airway. In the airways of the lung, the transfer of energy into the airway tissue stiffens that tissue or reduces the ability of the airways to constrict. In general the treatment reduces the resistance to the flow of air through the airway.
  • 2. Brief Description of the Related Art
  • Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. However, asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
  • Asthma stimuli may be allergenic or non-allergenic. Examples of allergenic stimuli include pollen, pet dander, dust mites, bacterial or viral infection, mold, dust, or airborne pollutants; non-allergenic stimuli include exercise or exposure to cold, dry air.
  • In asthma, chronic inflammatory processes in the airway play a central role. Many cells and cellular elements are involved in the inflammatory process, particularly mast cells, eosinophils T lymphocytes, neutrophils, epithelial cells, and even airway smooth muscle itself. The reactions of these cells result in an associated increase in the existing sensitivity and hyperresponsiveness of the airway smooth muscle cells that line the airways to the particular stimuli involved.
  • The chronic nature of asthma can also lead to remodeling of the airway wall (i.e., structural changes such as thickening or edema) which can further affect the function of the airway wall and influence airway hyperresponsiveness. Other physiologic changes associated with asthma include excess mucus production, and if the asthma is severe, mucus plugging, as well as ongoing epithelial denudation and repair. Epithelial denudation exposes the underlying tissue to substances that would not normally come in contact with them, further reinforcing the cycle of cellular damage and inflammatory response.
  • In susceptible individuals, asthma symptoms include recurrent episodes of shortness of breath (dyspnea), wheezing, chest tightness, and cough. Currently, asthma is managed by a combination of stimulus avoidance and pharmacology.
  • Stimulus avoidance is accomplished via systematic identification and minimization of contact with each type of stimuli. It may, however, be impractical and not always helpful to avoid all potential stimuli.
  • Asthma is managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both approaches require repeated and regular use of the prescribed drugs. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. Patient compliance with pharmacologic management and stimulus avoidance is often a barrier to successful asthma management.
  • Asthma is a serious disease with growing numbers of sufferers. Current management techniques are neither completely successful nor free from side effects.
  • Accordingly, it would be desirable to provide an asthma treatment which improves airflow without the need for patient compliance.
  • In addition to the airways of the lungs, other body conduits such as the esophagus, ureter, urethra, and coronary arteries, are also subject to periodic spasms that interfere with their normal function.
  • SUMMARY OF THE INVENTION
  • The present invention relates to a device for treating airway tissue within the lungs by transfer of energy into the walls of the airway to reduce plugging of the airway, to prevent the airway from being able to constrict, to increase the inner airway diameter, or to reduce resistance to flow through the airway. The invention is particularly directed to the treatment of the airways in the lungs to reduce the effects of asthma and other lung disease. One variation of the invention includes the transfer of energy to the airway wall via the application of heat.
  • The present invention provides devices to decrease airway responsiveness and airway resistance to flow which may augment or replace current management techniques. In accordance with one variation of the present invention, an energy transfer apparatus for treating conditions of the lungs by decreasing airway responsiveness includes transferring energy into an airway wall to alter the airway wall in such a manner that the responsiveness of the airway is reduced.
  • In particular, the inventive device is an energy transfer apparatus which facilitates energy transfer with a mass of tissue within the airways of a lung. The inventive device is sized to enter the bronchus or bronchiole of a human lung to conduct energy transfer with the airway tissue therein. The inventive device may also be sized to fit within a bronchoscope. The bronchoscope may have a channel with a diameter of preferably 2 mm or less.
  • A variation of the inventive device includes a flexible elongated body having a proximal portion and a distal portion with a lumen extending between the proximal and distal portions. The flexible elongated body may be of sufficient stiffness to pass through a seal of a working channel of a bronchoscope and allow operation of the device through the working channel seal. The device may include an expandable portion that is adjacent to a distal portion of the elongated body. The expandable portion has a first state, e.g., a size, and a second state where the second state is radially expanded in size from the elongated body. The device may include a temperature detecting element which is placed near to the expandable portion. The device also includes at least one energy transfer element at an exterior of the expandable portion, where the energy transfer elements are configured to contact the wall of the bronchus or bronchiole when the expanded portion is in an expanded state. The device may also include a deployment member that is configured to move the expandable portion between the first and second radially expanded states. The deployment member may extend between the expandable portion and the proximal portion of the elongated body. The inventive device may further include a distal tip located at a distal end of the apparatus. One variation of the inventive device includes an expandable portion that has a diameter of less than 15 mm when in a second expanded state.
  • Another variation of the invention includes an expandable portion which includes pre-shaped tines. Such tines are configured to be in a first state within an elongated body and, when advanced out of the elongated body, to expand into a second expanded state. The tines may be connected to each other with an expanding element to prevent the tines from entering multiple airways at a bifurcation.
  • Another variation of the invention includes an expandable portion comprised of a balloon. This variation of the invention may include the use of a fluid which may expand the balloon into the second state. Yet another variation of this invention includes the use of a heat generating element in the balloon which conducts heat to the fluid to heat an exterior of the balloon. In this variation, the exterior of the balloon serves as the energy transfer element.
  • A further variation of the inventive device includes an expandable portion which comprises a plurality of legs which forms a basket. The legs of this variation may extend from a proximal joint that is found at an intersection of a distal portion of the elongated body to a distal joint that is adjacent to a distal tip. Each leg may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg. The center that is substantially parallel is usually referred to as the active region of the leg. The
  • The legs of this variation may be spaced around a circumference of the elongated body to form a basket. The legs of this variation may have a circular cross section or a rectangular cross section, or other non-axisymmetric cross sections. The cross sections may be chosen to allow ready deployment from a first state to a second expanded state, while resisting out-of-plane bending which may distort the spacing of the legs or the contact of electrodes with the airway surface. One variation of the invention includes a basket in which the distance between the proximal and distal joint is less than 35 mm when the basket is not expanded. Another variation of this invention includes a basket that comprises four or five legs. In this case, the legs may be placed evenly around a circumference of the elongated body. In this case the legs may be found at intervals of 90 or 72 degrees. Other variations of the invention include devices having less than four legs or more than five legs. Another variation of this inventive device includes placing a temperature detecting element on one or on more legs. In this variation, the temperature of one leg may be monitored or the temperature of several legs may be independently monitored to control the energy delivery. In a further variation, multiple temperature sensing elements may be combined with independent control of energy to each leg. Both of these variations may also apply to a variation of the device having pre-shaped tines. The legs may be soldered or made to adhere using adhesives to the elongated body at the proximal and distal ends. Another variation of the invention includes a multi-lumen elongated body into which a portion of each leg is inserted. It is also contemplated that an elongated member may be reinforced via a reinforcing member. Such a reinforcing member may include a coiled or braided wire, polymeric insert, or any other similar reinforcing member.
  • The energy transfer element of the invention may include an element that directly heats tissue by delivering current such as an RF based electrode. The RF electrode may be either bipolar or monopolar or a heated element that conductively heats tissue. In variations of the invention using RF energy, the frequency of the RF may be selected to be in the 400 kHz range or any other standard medical range used in electro-surgical applications.
  • When the electrode directly heats the tissue, the heated element may use AC or DC current to resistively heat the element. RF energy may also be used to resistively heat the element. An indirect method of heating includes a resistively heated element that conducts heat to the expandable portion or directly to the airway. The invention may also include a combination of the types of electrodes mentioned above.
  • In the variation of the invention in which the expandable portion comprises a basket, each of the energy transfer elements may be a RF electrode that is attached to each leg. The electrode may be fastened by a heat shrink fastener. In such a case, a temperature detecting element may be placed on the leg and underneath the fastener. A resistance heating element may be coiled around a portion of the leg. In this case, a temperature detecting element may be placed underneath the coil. Other examples of the energy transfer element include a polymeric heating element, an electrically conductive paint, or a printed flex circuit which are on a portion of the leg. Another variation employs the basket leg itself as either a RF electrode or a heated element. In such cases, the temperature sensing element may be attached directly to a basket leg by soldering, welding, adhesive bonding, or other means.
  • Another variation of the invention includes a sheath slidably coupled to and exterior to the expandable portion. The expandable portion may be resilient and self-expand into the second state when no longer confined by the sheath. For example, the sheath may be withdrawn in a proximal direction or the expandable portion may be advanced out of the sheath.
  • Yet another variation of the invention includes a deployment member comprising a handle adjacent to a proximal end of the elongated body. The elongated body may be slidably attached to the handle. The deployment member may also comprise a wire that extends from the handle through the lumen of the elongated body and is fixedly attached to the distal tip. This wire may also provide a current to the energy transfer members. The elongated body, the wire, and the distal tip may be slidably moveable in a distal and proximal direction. This variation of the deployment member may also include a stop configured to prevent distal movement of the wire beyond a deployment point. In this variation, beyond the deployment point, movement of the elongated body against the non-moving distal tip causes the expansion member to expand from a first state into a second expanded state.
  • Another variation of the invention includes a deployment member comprising a sheath that covers the elongated member and expandable portion and a handle at a proximal end of the sheath. The sheath may be slidably attached to the handle while the elongated member is rigidly attached to the handle. A wire may extend from said handle to a distal tip through a lumen of the elongated member. The variation may include a first control member attached to the sheath and slidably attached to the handle where proximal movement of the first control member causes the sheath to retract on the elongated member and uncover the expandable portion. This variation may also include a second control member which is attached to the wire where proximal movement of the second control member causes the distal tip and the expandable portion to retract against the non-moving elongated member and causes the expandable portion to radially expand into a second state.
  • Another variation of the invention includes a deployment member having force compensation or deflection limiting stops to prevent over-expansion of the expandable member when deployed within the body.
  • A variation of the invention includes placing a sheath exterior to the elongated body and expandable portion such that the expandable portion is placed within the sheath in a first unexpanded state. When the expandable portion is no longer restrained by the sheath, the expandable portion expands into its second state. The invention may also include a control member moveably secured to the handle where the member is configured to advance the elongated body and the wire in the distal and proximal directions. Another variation of the invention includes a detent means for maintaining the elongated body distally of the deployment point. The control member may also be configured to frictionally maintain the elongated body distally of the deployment point. In these cases, the expandable portion will be in the second expanded state. Other variations of the inventive device may include use of levers, control wheels, or screw mechanisms in place of a control member.
  • Another variation of the inventive device includes a distal tip that may be configured to prevent gouging of the airway tissue. The distal tip may have a redundant joint to prevent separation of the tip from the apparatus. The distal tip may also be sized to fit within a bronchoscope.
  • Another variation of the invention includes a central wire extending from the distal tip to the proximal portion of the device. The wire may be configured to provide a current to the energy transfer elements. A temperature detecting element may also be attached to the wire.
  • The inventive device may also be radiopaque or may have radiopaque elements.
  • Another variation of the invention includes providing a steering member in the device to deflect the distal tip of the apparatus in a desired direction.
  • Another variation of the invention includes placing a vision system on the apparatus. The vision system may include a fiber-optic cable or a CCD chip.
  • Another variation of the invention includes providing a power supply configured to deliver energy through the energy transfer elements to the airway walls. The power supply may be configured to include a high temperature shut off or one which shuts down if a minimum temperature is not detected within a predetermined time or if a minimum temperature slope is not detected during a predetermined time.
  • The invention further includes a kit comprising an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue and a generator configured to delivery energy to the energy transfer apparatus. The kit may further include a bronchoscope.
  • The invention further includes an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue within a lung, the energy transfer apparatus having been rendered sterile for the purposes of prevention of infection of the lung.
  • The invention further includes a modified lung configured to have an artificially altered airway within the lung, the airway being artificially altered by transfer of energy to the airway such that the airway has a reduced ability to constrict, an increased airway diameter, a increase in resistance to plugging, and a decrease in resistance to airflow.
  • The present invention may be used for a treatment of asthma or other constriction or spasm of a bodily conduit by application of energy. The treatment reduces the ability or propensity of the airway to contract, reduces plugging of the airway, increases the inner airway diameter, and/or reduces resistance to flow through the airway.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will now be described in greater detail with reference to the various embodiments illustrated in the accompanying drawings:
  • FIG. 1 is a cross sectional view of a medium sized bronchus in a healthy patient.
  • FIG. 2 is a cross sectional view of a bronchiole in a healthy patient.
  • FIG. 3 is a cross sectional view of the bronchus of FIG. 1 showing the remodeling and constriction occurring in an asthma patient.
  • FIG. 4 is an illustration of the lungs being treated with a device according to the present invention.
  • FIG. 5A is a partial side view of a variation of the inventive device having a plurality of wire shaped electrodes.
  • FIG. 5B is a cross sectional side view of another variation of a device having a plurality of wire shaped electrodes with a deployment wire attached to a distal tip of the device.
  • FIG. 5C shows a partial view of a variation of an elongated member of inventive device having a plurality of lumens for nesting the legs of the basket.
  • FIGS. 5D-5I illustrate a variation of the invention and a deployment member for deploying the device.
  • FIGS. 5J-5L illustrate examples of energy transfer elements of the device.
  • FIG. 5M shows a partial view of a thermocouple attached to a basket leg.
  • FIGS. 6A-6D illustrates distal joints of the invention.
  • FIG. 6E illustrates a proximal joint of the invention.
  • FIGS. 7A-7D illustrates a series and parallel wiring of legs of the basket.
  • FIGS. 8A-8C illustrate examples of variable thicknesses of legs of the basket.
  • FIGS. 9A-9D illustrate examples of a basket formed from a single sheet or piece of material.
  • FIG. 10 is a side cross sectional view of a variation of the inventive device having a balloon with electrodes positioned exterior to the balloon.
  • FIG. 11 is a partial side view of a variation of the inventive device having a balloon with heat generating elements positioned within the balloon for indirect heating of the tissue.
  • FIG. 12 is cross sectional view of the inventive device with electrodes and pre-shaped tines as the expandable member.
  • FIG. 13 is a cross sectional view of a variation of the inventive device with energy transfer elements positioned on expandable balloons.
  • FIG. 14 is an illustration of a variation of the inventive device with electrodes positioned in grooves.
  • FIG. 15 is an illustration of a variation of the inventive device with electrodes and a biasing element.
  • FIG. 16 is an illustration of another variation of the inventive device having electrodes and a biasing element.
  • FIG. 17 is a partial side view of a variation of the inventive device having electrodes exposed by cut away sections of an elongated member.
  • FIG. 18 is a partial side view of the inventive device with electrodes positioned on a loop shaped member.
  • FIG. 19 is a cross sectional view of a variation of the inventive device having a looped shaped electrode in an unexpanded position.
  • FIG. 20 is a cross sectional view of the variation of FIG. 19 with the looped shape electrode in an expanded position.
  • DETAILED DESCRIPTION Reducing the Ability of the Airway to Contract
  • The inventive airway energy treatment may be used to reduce the ability of the airways to narrow or to reduce in diameter due to airway smooth muscle contraction. This treatment to reduce the ability of the smooth muscle to contract lessens the severity of an asthma attack. The reduction in the ability of smooth muscle to contract may be achieved by treating the smooth muscle itself or by treating other tissues which in turn influence smooth muscle contraction or the response of the airway to smooth muscle contraction. Treatment may also reduce airway responsiveness or the tendency of the airway to narrow or to constrict in response to a stimulus.
  • The amount of smooth muscle surrounding the airway can be reduced by exposing the smooth muscle to energy which either kills the muscle cells or prevents these cells from replicating. The reduction in smooth muscle reduces the ability of the smooth muscle to contract and to narrow the airway during a spasm. The reduction in smooth muscle and surrounding tissue has the added potential benefit of increasing the caliber or diameter of the airways, reducing the resistance to airflow through the airways. In addition to use in debulking smooth muscle tissue to open up the airways, the device of the present invention may also be used for eliminating the smooth muscle altogether by thermally damaging or destroying it. The elimination of the smooth muscle prevents the hyper-reactive airways of an asthma patient from contracting or spasming, reducing or eliminating this asthma symptom.
  • The ability of the airway to contract can also be altered by treatment of the smooth muscle in particular patterns. The smooth muscle is arranged around the airways in a generally helical pattern with pitch angles ranging from about −30 to about +30 degrees. Thus, the treatment of the smooth muscle by energy which is selectively delivered in an appropriate pattern interrupts or cuts through the helical pattern at a proper pitch and prevents the airway from constricting. This procedure of patterned application of energy eliminates contraction of the airways without completely eradicating smooth muscle and other airway tissue. A pattern for treatment may be chosen from a variety of patterns including longitudinal or axial stripes, circumferential bands, helical stripes, and the like as well as spot patterns having rectangular, elliptical, circular or other shapes. The size, number, and spacing of the treatment bands, stripes, or spots are chosen to provide a desired clinical effect of reduced airway responsiveness while limiting insult to the airway to a clinically acceptable level.
  • The patterned treatment of the tissues surrounding the airways with energy provides various advantages. The careful selection of the portion of the airway to be treated allows desired results to be achieved while reducing the total healing load. Patterned treatment can also achieve desired results with decreased morbidity, preservation of epithelium, and preservation of a continuous or near continuous ciliated inner surface of the airway for mucociliary clearance. The pattern of treatment may also be chosen to achieve desired results while limiting total treatment area and/or the number of airways treated, thereby improving speed and ease of treatment.
  • Application of energy to the tissue surrounding the airways also may be used to cause the DNA of the cells to become cross linked. The treated cells with cross linked DNA are incapable of replicating. Accordingly, over time, as the smooth muscle cells die, the total thickness of smooth muscle decreases because of the inability of the cells to replicate. The programmed cell death causing a reduction in the volume of tissue is called apoptosis. This treatment does not cause an immediate effect but causes shrinking of the smooth muscle and opening of the airway over time and substantially prevents re-growth. The application of energy to the walls of the airway may also be used to cause a cross linking of the DNA of the mucus gland cells thereby preventing them from replicating and reducing excess mucus plugging or production over time.
  • The ability of the airways to contract may also be reduced by altering mechanical properties of the airway wall, such as by increasing stiffness of the wall or by increasing parenchymal tethering of the airway wall. Both of these methods increase the strength of the airway wall and opposes contraction and narrowing of the airway.
  • There are several ways to increase the stiffness of the airway wall. One way to increase stiffness is to induce fibrosis or wound healing response by causing trauma to the airway wall. The trauma can be caused by delivery of therapeutic energy to the tissue in the airway wall or by mechanical insult to the tissue. The energy is preferably delivered in such a way that it minimizes or limits the intra-luminal thickening that can occur.
  • Another way to increase the effective stiffness of the airway wall is by altering the submucosal folding of the airway upon narrowing. The submucosal layer is directly beneath the epithelium and its basement membrane and inside the airway smooth muscle. As an airway narrows, its perimeter remains relatively constant, with the mucosal layer folding upon itself. As the airway narrows further, the mucosal folds mechanically interfere with each other, effectively stiffening the airway. In asthmatic patients, the number of folds is fewer and the size of the folds is larger, and thus, the airway is free to narrow with less mechanical interference of mucosal folds than in a healthy patient. Thus, asthmatic patients have a decrease in airway stiffness and the airways have less resistance to narrowing.
  • The mucosal folding in asthmatic patients can be improved by treatment of the airway in a manner which encourages folding. Preferably, a treatment will increase the number of folds and/or decrease the size of the folds in the mucosal layer. For example, treatment of the airway wall in a pattern such as longitudinal stripes can encourage greater number of smaller mucosal folds and increase airway stiffness.
  • The mucosal folding can also be increased by encouraging a greater number of smaller folds by reducing the thickness of the submucosal layer. The decreased thickness of the submucosal layer may be achieved by application of energy which either reduces the number of cells in the submucosal layer or which prevents replication of the cells in the submucosal layer. A thinner submucosal layer will have an increased tendency to fold and increased mechanical stiffening caused by the folds.
  • Another way to reduce the ability of the airways to contract is to improve parenchymal tethering. The parenchyma surrounds airways and includes the alveolus and tissue connected to and surrounding the outer portion of the airway wall. The parenchyma includes the alveolus and tissue connected to and surrounding the cartilage that supports the larger airways. In a healthy patient, the parenchyma provides a tissue network which connects to and helps to support the airway. Edema or accumulation of fluid in lung tissue in asthmatic patients is believed to decouple the airway from the parenchyma reducing the restraining force of the parenchyma which opposes airway constriction. Application of therapeutic energy can be used to treat the parenchyma to reduce edema and/or improve parenchymal tethering.
  • In addition, the applied energy may be used to improve connection between the airway smooth muscle and submucosal layer to the surrounding cartilage, and to encourage wound healing, collagen deposition, and/or fibrosis in the tissue surrounding the airway to help support the airway and prevent airway contraction.
  • Increasing the Airway Diameter
  • Airway diameter in asthmatic patients is reduced due to hypertrophy of the smooth muscle, chronic inflammation of the airway tissues, and general thickening of all parts of the airway wall. The overall airway diameter can be increased by a variety of techniques to improve the passage of air through the airways. Application of energy to the airway smooth muscle of an asthmatic patient can be used to debulk or reduce the volume of smooth muscle. This reduced volume of smooth muscle increases the airway diameter for improved air exchange.
  • The airway diameter can also be increased by reducing inflammation and edema of the tissue surrounding the airway. Inflammation and edema (accumulation of fluid) of the airway occur in an asthmatic patient due to irritation. The inflammation and edema can be reduced by application of energy to stimulate wound healing and regenerate normal tissue. Healing of the epithelium or sections of the epithelium experiencing ongoing denudation and renewal allows regeneration of healthy epithelium with less associated airway inflammation. The less inflamed airway has an increased airway diameter both at a resting state and in constriction. The wound healing can also deposit collagen which improves parenchymal tethering.
  • Inflammatory mediators released by tissue in the airway wall may serve as a stimulus for airway smooth muscle contraction. Smooth muscle contraction, inflammation, and edema can be reduced by a therapy which reduces the production and release of inflammatory mediators. Examples of inflammatory mediators are cytokines, chemokines, and histamine. The tissues which produce and release inflammatory mediators include airway smooth muscle, epithelium, and mast cells. Treatment of these structures with energy can reduce the ability of the airway structures to produce or release inflammatory mediators. The reduction in released inflammatory mediators will reduce chronic inflammation, thereby increasing the airway inner diameter, and may also reduce hyper-responsiveness of the airway smooth muscle.
  • A further process for increasing the airway diameter is by denervation. A resting tone of smooth muscle is nerve regulated by release of catecholamines. Thus, by damaging or eliminating nerve tissue in the airways the resting tone of the smooth muscle will be reduced, and the airway diameter will be increased.
  • Reducing Plugging of the Airway
  • Excess mucus production and mucus plugging are common problems during both acute asthma exacerbation and in chronic asthma management. Excess mucus in the airways increases the resistance to airflow through the airways by physically blocking all or part of the airway. Excess mucus may also contribute to increased numbers of leukocytes found in airways of asthmatic patients by trapping leukocytes. Thus, excess mucus can increase chronic inflammation of the airways.
  • One type of asthma therapy involves treatment of the airways with energy to target and reduce the amount mucus producing cells and glands and to reduce the effectiveness of the remaining mucus producing cells and glands. The treatment can eliminate all or a portion of the mucus producing cells and glands, can prevent the cells from replicating or can inhibit their ability to secrete mucus. This treatment will have both chronic benefits in increasing airflow through the airways and will lessen the severity of acute exacerbations.
  • Illustrated below are different treatment devices for transferring energy into the airways. Described below are just some of the examples of the type of treatment devices which may be used to treat airway tissue according to the present invention. It should be recognized that each of the treatment devices described below can be modified to deliver or to remove energy in different patterns depending on the treatment to be performed. The treatment devices may be actuated continuously for a predetermined period while stationary, may be pulsed, may be actuated multiple times as they are moved along an airway, may be operated continuously while moving the device in an airway to achieve a “painting” of the airway, or may be actuated in a combination of any of these techniques. The particular energy application pattern desired can be achieved by configuring the treatment device itself or by moving the treatment device to different desired treatment locations in the airway.
  • The treatment of an airway with the treatment device may involve placing a visualization system such as an endoscope or bronchoscope into the airways. The treatment device is then inserted through or next to the bronchoscope or endoscope while visualizing the airways. Alternatively, the visualization system may be built directly into the treatment device using fiber optic imaging and lenses or a CCD and lens arranged at the distal portion of the treatment device. The treatment device may also be positioned using radiographic visualization such as fluoroscopy or other external visualization means. The treatment device which has been positioned with a distal end within an airway to be treated is energized so that energy is applied to the tissue of the airway walls in a desired pattern and intensity. The distal end of the treatment device may be moved through the airway in a uniform painting like motion to expose the entire length of an airway to be treated to the energy. The treatment device may be passed axially along the airway one or more times to achieve adequate treatment. The “painting-like” motion used to exposed the entire length of an airway to the energy may be performed by moving the entire treatment device from the proximal end either manually or by motor. Alternatively, segments, stripes, rings or other treatment patterns may be used.
  • According to one variation of the invention, the energy is transferred to or from an airway wall in the opening region of the airway, preferably within a length of approximately two times the airway diameter or less, and to wall regions of airways distal to bifurcations and side branches, preferably within a distance of approximately twice the airway diameter or less. The invention may also be used to treat long segments of un-bifurcated airway.
  • Decreasing Resistance to Airflow
  • There are several ways to decrease the resistance to airflow though the airways which occurs in asthma patients both at rest and during an asthma attack. One such treatment alters the structure of the airway, such as by reducing the amount of airway tissue. For example, the addition of energy to the airway tissue may cause the DNA of the muscle cells to become cross linked. The smooth muscle cells with cross linked DNA cannot replicate. Thus, over time, as smooth muscle cells die, the total thickness of the muscle decreases because of the inability of the cells to replicate. Another treatment alters the function of the airway, such as by reducing smooth muscle contraction, mucus gland secretions, or disrupting the inflammatory response. These treatments can be performed by applying energy of different types and in different patterns to achieve the desired results. In such cases, stiffness of the airway is increased as the energy induces a fibrosis or wound healing response that causes trauma to the airway wall.
  • FIGS. 1 and 2 illustrate cross sections of two different airways in a healthy patient. The airway of FIG. 1 is a medium sized bronchus having an airway diameter D1 of about 3 mm. FIG. 2 shows a section through a bronchiole having an airway diameter D2 of about 1.5 mm. Each airway includes a folded inner surface or epithelium 10 surrounded by stroma 12 and smooth muscle tissue 14. The larger airways including the bronchus shown in FIG. 1 also have mucous glands 16 and cartilage 18 surrounding the smooth muscle tissue 14. Nerve fibers 20 and blood vessels 22 also surround the airway.
  • FIG. 3 illustrates the bronchus of FIG. 1 in which the smooth muscle 14 has hypertrophied and increased in thickness causing the airway diameter to be reduced from the diameter D1 to a diameter D3.
  • FIG. 4 is a schematic side view of the lungs being treated with an energy transferring apparatus 30 according to the present invention. The device 30 is an elongated member for facilitating exchanging energy with a mass of airway tissue at a treatment site 34 within the lungs. The device 30 must be of a size to access the bronchus or bronchioles of the human lung. The device may be sized to fit within bronchoscopes, preferably, with bronchoscopes having a working channel of 2 mm or less. Also, the device should be of sufficient stiffness to fit and operate through the seal covering the working channel a bronchoscope.
  • The energy may be delivered by the treatment device 30 in a variety of treatment patterns to achieve a desired response. Examples of patterns are discussed in further detail below. The energy which is delivered by the treatment device 30 may be any of a variety of types of energy including, but not limited to, radiant, laser, radio frequency, microwave, heat energy, or mechanical energy (such as in the form of cutting or mechanical dilation).
  • Also, the device may, but is not necessarily, configured to deliver energy in non-intersecting strip patterns which are parallel with a central axis of an airway. For example, other variations of the device may be configured to deliver energy in a torsional pattern, or in a circumferential pattern around a wall of the airway. Such configurations which may be determined to deliver energy to the airway tissue that maximize the ability of the airway to permit airflow are considered to be within the scope of this invention.
  • The inventive devices include tissue contacting electrodes configured to be placed within the airway. These devices can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated elements. As shown in FIG. 4, for monopolar energy delivery, one or more electrodes of the treatment device are connected to a single pole of the energy source 32 and an optional external electrode 44 is connected to an opposite pole of the energy source. For bipolar energy delivery, multiple electrodes are connected to opposite poles of the energy source 32 and the external electrode 44 is omitted. Naturally, the external electrode 44 depicted in FIG. 4, is not required in the case of bipolar energy delivery. The number and arrangement of the electrodes may vary depending on the pattern of energy delivery desired. The treatment devices of FIGS. 5A-10, and 12-20 are used to deliver radiant or heat energy to the airway. The treatment device of FIG. 11 may also be used to deliver indirect radio frequency, microwave energy, or conductive heat energy to the tissue. In cases of heat energy generated by resistive heating, the current may be AC or DC current or in the case of AC, the current may be delivered in the RF range. The use of RF provides an added safety feature of minimizing the possibility of harm to the patient caused by escaped current. The device may also use a combination of any of the energy transferring element configurations described herein.
  • The following illustrations are examples of the invention described herein. It is contemplated that combinations of aspects of specific embodiments or combinations of the specific embodiments themselves are within the scope of this disclosure.
  • The treatment device 302 of FIG. 5A includes an elongated member 102 for delivering an expandable member 104 to a treatment site. The expandable member 104 may have a plurality of energy transfer elements (not illustrated) which are placed on a plurality of basket legs 106 to transfer energy at the treatment site. In this variation, the expandable member comprises a basket 104 which is defined by a number of basket legs 106. The basket legs 106 are formed from a plurality of elements which are soldered or otherwise connected together at two connection areas, a proximal joint 108 and a distal joint 110.
  • A desirable length of the basket 104, or the expandable portion of any variation of the invention, depends upon numerous factors. One consideration in determining a desired length of the expandable member, e.g., the distance between the joints of the basket, of the inventive device is related to the dimension of the target area or treatment region. For instance, some other factors include considerations of minimizing the amount of the expandable portion which is distal to the treatment region for optimized access, minimizing the amount of the expandable portion that is proximal to the treatment region for visualization and access concerns, and setting a desirable length of the expandable portion that will contact a sufficient portion of the treatment region during each application of the device. A compromise of such factors along with other considerations provides a desirable length for the expandable portion of the device. Preferably, the distance between the distal and proximal joints of the basket is less than 35 mm when the basket is in a first unexpanded state.
  • The legs 106 may be selected from a material that allows the basket to expand without plastic deformation. For example, the legs may comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material. The basket legs 106 may have a rectangular cross section in those variations where the legs 106 are formed from ribbons, or the legs 106 may have a circular cross section in those variations where the legs are formed from wires. As discussed below, the legs 106 may also have other cross section as desired. It is also contemplated that the legs 106 need not all have similar cross sections. For instance, the cross section of each of the legs 106 in a basket 104 may be individually chosen to optimize such factors as the resilience of the basket 104, or to optimize energy transfer characteristics. The legs may also have a variable cross section along the length of the basket.
  • Illustrated are variations of the inventive device 302 having a basket 104 comprising of four legs 106. It is preferred that the legs 106 are spaced at equal intervals around the expandable member or basket 104. For example, in variations of the invention having four legs 106, the legs 106 are preferably, but not necessarily spaced at approximately 90 degree intervals around the basket 104. In variations having five legs 106, the legs 106 may be spaced at approximately 72 degree intervals. Other variations of the invention include devices having less than four legs or more than five legs. It is thought that the most effective number of legs is a compromise based on the size of the target airway, contact surface between the leg 106 and airway wall, and the maximum outer diameter of the elongated member 102.
  • The proximal 108 and/or distal 110 joints may also contain adhesive to bind the legs 106. The basket legs 106 between the proximal 108 and distal joint 110 are formed into the basket shape 104 so that arch shaped portions of the basket legs 106 will contact the walls of an airway to facilitate energy transfer. Although the figures illustrate the basket legs 106 as having a semi-circular or arc shape the device is not limited to such shapes. For example, the legs 106 may have a more oblong shape or sharper bends to allow for a more parallel leg surface area that contacts the target tissue. Each leg 106 may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg 106. The center that is substantially parallel is usually referred to as the active region of the leg 106.
  • The length of the basket 104 between the proximal and distal 110 joints may be less than 35 mm when the basket 104 is in a first unexpanded state. The legs 106 may be coated with an insulating material (not shown) except at the tissue contact points. Alternatively, the legs 106 of the basket 104 may be exposed while the proximal 108 and distal joint 110 are insulated. In this variation, the basket 104 is formed of a resilient material which allows the distal end of the inventive device 302 to be confined by a sheath (not shown) for delivery of the device 302 to the treatment site and allows the basket 104 to return to its original basket shape upon deployment. In other words, a variation of the invention is that the basket self-expands from a first state to a second expanded state upon the removal of any constraining or restrictive member such as a sheath (not shown). The inventive device 302 is preferably configured such that the basket legs 106 have sufficient resilience to come into contact with the airway walls for treatment.
  • FIG. 5A further illustrates a variation of the inventive device 302 in which a distal end of the device 302 is provided with a distal tip 112 that can have a radius to facilitate insertion of the device 302 into the lungs and also to minimize the possibility of causing trauma to surrounding tissue. The tip 112 is preferably sized to prevent the gouging of airway by the sheath. The design of the distal tip is selected to be atraumatic. The size of the tip may be selected to be large enough to prevent the sheath from gouging airways yet small enough to pass in and out of a bronchoscope.
  • FIG. 5B illustrates a variation of the inventive device 302 having basket legs 108 connected to a distal end 114 of the elongated member 102 and forming a basket 104. In this variation, a proximal joint is found at the distal end 114 of the elongated member 102. The basket 104 is expanded radially, to its second state, during use to ensure contact between the energy transfer elements (not shown) and the airway walls (not shown) by, for example, pulling on a center pull wire 116 which is connected to a distal tip 118 of the expandable portion 104. The center pull wire 116 may extend through a lumen of the elongated member 102 towards a proximal portion (not shown) of the elongated member 102. It is also contemplated that the center pull wire 116 may be configured to deliver current to the energy transfer elements found on the expandable member 104. The inventive device 302 may be delivered to a treatment site through a delivery sheath 120 and may be drawn along or moved axially along the airway to treat the airway in a pattern of longitudinal or helical stripes.
  • As noted above, the basket 104 may be resilient or self-expanding (e.g., see FIG. 5A) to expand to a second expanded state or the basket 104 may require an expanding force (e.g., see FIG. 5B). An example of this variation of the inventive device 304 is shown in FIG. 5B. In this variation, the basket 104 may be resilient and the sheath 120 may comprise the deployment member. In this variation, when the elongate body 102 and basket 104 are withdrawn into the sheath 120, the basket 104 contracts within the sheath 120 and assumes a first state. In one variation of the invention, upon advancing the basket 104 and elongate body 102 out of the sheath 120, the basket 104 may resiliently assume a second expanded state. In another variation of the invention, the basket 104 may assume a second expanded state with the aid of a wire 116. This wire may also be configured to deliver power to the energy exchange elements 106.
  • FIG. 5C illustrates another variation of the inventive device where an elongated member 102 of is configured to have a plurality of lumens 140 so that each of the basket legs 106 are isolated within the lumens 140 of the elongated member 102 until the legs 106 exit the elongated member 102 and connect at a proximal joint 108. The invention may have basket legs 106 selected with a sufficient length such that the ends of each of the legs 106 extend substantially into the lumens 140. As a result of being inserted deeply within the lumen, the ends of the legs 106 would require significant travel before they exited the lumen 140. This feature provides added safety as it minimizes the risk of the basket legs 106 dislodging from the elongate member 102.
  • In another variation of the invention, the elongated member 102 may comprise concentric tubes (not shown) rather than multi-lumen tubes where basket legs are inserted in the annulus between the tubes. It is also contemplated that an elongated member may be reinforced with the use of a reinforcing member. Such a reinforcing member may include a coiled wire or polymeric insert.
  • FIG. 5D-5I illustrate variations of the inventive device that use an expanding force to expand the basket. FIG. 5D illustrates a deployment member of the device. FIG. 5E illustrates the device of FIG. 5D when the elongated member is moved in a distal direction to a deployment point. FIG. 5F-5G illustrates the elongated member 102, sheath 120, expandable member 104, distal tip 118, and wire 122 extending through the device. FIG. 5F illustrates the basket 104 in a first unexpanded state when the elongated member 102 and wire 122 are proximal of the deployment point 130. FIG. 5G illustrates the expansion of the basket 104 to a second expanded state as the elongated member 102 moves distally and the wire 122 is restrained at the deployment point 130.
  • Turning now to FIG. 5D, the deployment member may comprise a handle 124 which is adjacent to a proximal portion of an elongated member 102. The handle may be designed to be operated by a single hand, either right or left. The handle may also have a control switch for operation of the device. Such a switch could control the power supply attached to the device as well. Also, the handle may be configured to determine the position of the device within a human body as the device is advanced to a target site. For example, marks on the handle or even a readout could provide information to the user as to the relative deployment state of the expandable member. Also, a sensor may be placed on the handle 124, this sensor may be used to determine the position of the expandable member. Such a sensor could also be used to measure the size of the airway, such a measurement could be used as a control variable to determine the amount of energy that the device power supply must deliver. The handle 124 may control the expandable member using force compensation (e.g., a spring, etc.) or deflection limiting stops to control the expansion of the expandable member. Such force compensation or deflection stops provide a limit to the expansion member to avoid over-expansion of a particular airway.
  • Turning now to the handle 124 of FIG. 5D, an elongated member 102 may be slidably mounted to the handle. The variation of the invention depicted in these Figures may also, but does not necessarily, include a sheath 120 exterior to the elongated body 102. A wire 122 extends from the handle through the elongated member 102 and may be attached to a distal tip 118 of the device. The wire 122, elongated member 102, and distal tip (not shown) are slidably moveable in both a distal and proximal directions. The handle may also include a stop 126 which prevents the wire 122 from moving distally beyond a deployment point 130. The stop 126 may be connected to a spring (not shown) to limit the expansion of the expandable member upon reaching a pre-determined force. The handle 124 may include a control member 128 that is moveably attached to the handle 124 for moving the elongated member 102 in a distal/proximal direction. Although the handle 124 in the figures is depicted to have a control member 128 as illustrated, other variations of control members are also contemplated to be within the scope of this invention. For example, though not illustrated, a handle 124 may include other configurations, such as lever, thumb-wheel, screw-mechanism, ratchet mechanism, etc., which are attached to the handle 124 to provide control actuation for the expandable member.
  • FIG. 5E illustrates a variation of the inventive device when the elongated member 102 and wire 122 are moved in a distal direction. In this illustrations, a stop 126 prevents the wire 122 from moving distally of a deployment position 130. This illustration further illustrates a variation of the invention where the stop 126 is attached to springs 127 which provide force compensation for the expandable member on the device. Although not shown, a control member 128 may have a stop which limits its travel along a handle 124. Such a stop is an example of a deflection limiting mechanism which controls the movement of the control member 128, thus controlling the extent of the expansion of the expandable member.
  • FIG. 5F illustrates the invention when the expandable member or basket 104 is in a first unexpanded state. As noted above, the wire 122 is attached to a distal tip 118 of the device and both are prevented from distal movement when the wire 122 is in the deployment position 130. Therefore, as depicted in FIG. 5G, movement of the elongated member 102 in a distal direction against a distal tip 118, that is restrained by a wire 122, causes a basket 104 to compress between the advancing elongated member 102 and the stationary distal end 118. Thus, the basket 104 is forced outward and radially expands into a second expanded state. As noted above, the wire 122 may also be used to transfer energy to or from the energy transfer elements found on the basket 104. Also, it is contemplated that the wire 122 may be a wire, a ribbon, a tube, or of any other equivalent structure. Also contemplated, but not shown, is a detent means for maintaining the elongated member in a distal position to expand the basket 104 against the distal tip 118 without the need for continual applied force by a user of the device. Also contemplated is a ratchet member, or friction member to maintain the basket 104 in the expanded state.
  • FIG. 5H illustrates another variation of a deployment member. In this variation, a sheath 120 may be slidably attached to a handle 124. In this variation, the elongate member 102 is rigidly attached to the handle 124. The sheath 120 may be attached to a first control member 129. A wire 122 extends through the elongate member 102 and is attached to the distal tip of the device (not shown). The wire 122 may be attached to a second control member 131. As indicated in FIG. 5I, proximal movement of the first control member 129 causes the sheath 120 to proximally retract over the elongate member 102 and uncover the expandable portion (not shown). Proximal movement of the second control member 131 causes the wire 122, distal joint, and expandable member to move against the non-moving elongate member 102 which causes the expandable member to expand into a second state.
  • Turning now to the energy transfer elements located on the expandable portion, FIG. 5J-5L illustrate examples of energy transfer elements that may be located on the expandable portion of the device. In the variation of the invention where the expandable portion comprises a basket having basket legs 106, the basket legs 106 may function as heat exchange elements. In other words, the device may be configured so that the leg is an electrode or the conductive heating element. In these variations, the leg 106 may be partially covered with an insulation only leaving an active region exposed for delivery of energy to the airways. Examples of such insulation include a heat shrink sleeve, a dielectric polymeric coating, or other material which may function as an insulator.
  • FIG. 5J illustrates an example of a basket leg 106 with an energy transferring element 132 coiled around the leg 106. In this example, the energy transferring element uses conductive heating and comprises a resistance heating element 132 coiled around the leg 106. FIG. 5K illustrates a variation of the invention having an RF electrode attached to the basket leg 106. The RF electrode may be attached to the basket leg 106 via the use of a fastener 134. For example, the electrode may be attached via the use of a heat shrink fastener 134, (e.g., polymeric material such as PET or polyethylene tubing).
  • FIG. 5L illustrates another variation of the invention where the energy transfer element is a printed circuit 138 that is situated around the leg 106 and secured to the leg. Also contemplated, but not shown for use as energy transfer elements are a polymeric heating material, an electrically conductive paint, a resistance element sputtered onto the leg in a pattern or formed on a substrate by photofabrication. Also, the basket leg itself may be chosen of appropriate size and resistivity to alloy dual use as a basket and energy transfer element. Many nickel-chromium alloys have both high specific resistance and significant spring-like properties. In any variation of the invention the use of adhesives or other coatings may also be used to secure the energy transfer element to the basket leg 106. Also, the energy transfer elements are not limited to what is illustrated in the drawings. It is also contemplated that other types of energy transferelements may be used such as radiant, laser, microwave, and heat energy.
  • FIG. 6A illustrates a variation of a distal tip 210 having a redundant joint. The distal tip 208 has a polymeric cap 210 covering the distal ends of the basket legs 106 and wire 212. The legs 106 are soldered 214 to the distal end of the wire 212. Also used to maintain the joint is an adhesive 216 substantially filling the polymeric cap 210. A multi-lumen piece 218 separates the legs 106 and wire 212. A side view of the multi-lumen piece 218 is shown in FIG. 6B. A multi-lumen tubing may be used for the multi-lumen piece 218. The ends 220 of the polymeric cap 210 may be heat formed or otherwise tapered down around the legs 106.
  • FIG. 6C illustrates another variation of a distal tip 222 having a redundant joint. The distal tip 222 has a polymeric cap 210 covering the distal ends of the basket legs 106 and wire 212. The legs 106 are soldered 214 to the distal end of the wire 212. Also used to maintain the joint is an adhesive 216 substantially filling the polymeric cap 210. A hypo-tube 224 covers the legs 106 and wire 212. A side view of the hypo-tube 224 is shown in FIG. 6D. The distal end of the hypo-tube 224 may be flared to seat a ball located on a distal end of the wire 212 and the legs 106. A proximal end of the hypo-tube 224 may be flared to provide greater interlock with ends 220 of the polymeric cap 210. As shown in FIG. 6C, the ends of the legs 106 taper outwards from the hypo-tube 224 and form an area with a diameter larger than the end of the cap 226 which may be tapered down around the legs 106 and wire 212. The ends 220 of the polymeric cap 210 may be heat formed or otherwise tapered down.
  • FIG. 6E shows another variation of the invention having a hoop or ring 228 at a proximal joint of the device. The hoop 228 may be soldered or welded to the legs 106 and keeps the legs 106 attached even if a joint fails between the legs and the elongate member 102. Also, the hoop 228 may electrically connect the legs, preventing disconnection of single leg 106 having a temperature sensing element attached.
  • The invention also includes a temperature detecting element (not shown). Examples of temperature detecting elements include thermocouples, infrared sensors, thermistors, resistance temperature detectors (RTDs), or any other apparatus capable of detecting temperatures or changes in temperature. The temperature detecting element is preferably placed in proximity to the expandable member. In the variation illustrated in FIG. 5C, a temperature sensor may be mounted along the pull wire 116. For the variations depicted in FIG. 5J-5L, a temperature sensor may be mounted between the energy transfer elements 132, 136, 138 and the leg 106. In one variation of the invention a temperature sensor is placed on a single basket leg 106 to provide a signal to control energy transfer. It is also contemplated that a temperature sensor may be placed on more than one basket leg 106, and/or on a central wire 116 to provide control for multiple areas of energy transfer. The temperature sensor may be placed on the inside of the basket leg 106 to protect the temperature sensor while still providing a position advantageous to determining the device temperature at the energy transfer element.
  • FIG. 5M illustrates a variation of the invention having thermocouple leads 139 attached to a leg 106 of the device. The leads may be soldered, welded, or otherwise attached to the leg 106. This variation of the invention shows both leads 139 of the thermocouple 137 attached in electrical communication to a leg 106 at separate joints 141. In this case, the temperature sensor is at the surface of the leg. This variation provides in case either joint becomes detached, the circuit will be open and the thermocouple 137 stops reading temperature. The device may also include both of the thermocouple leads as having the same joint.
  • FIG. 7A-7D illustrate variations of the device in which impedance may be varied by wiring the basket legs 106 in series or in parallel. FIG. 7A illustrates a series wiring diagram in which a current path 142 flows from a first leg to a second leg 106, a third leg 106, and a fourth leg 106 sequentially. FIG. 7B illustrates the series wiring diagram and shows a single wire 143 connecting the legs 106 in series. The wire 143 may, for example, extend to a distal end of the leg and wrap over itself to the proximal end of the leg 106. A covering (not shown) may be placed over the wire 143 wrapped leg 106 at the proximal end of the device. FIG. 7C illustrates another variation of a series wiring diagram. In this example, a wire 143 extends from the proximal end of a leg 106 to its distal end and then extends to the distal end of an adjacent leg 106 and extends back to the proximal end of the adjacent leg 106.
  • FIG. 7D illustrates a parallel wiring diagram in which a current path 142 flows to each leg 106. Series wiring has an added advantage in that all current will pass through each energy transfer element. By design, this configuration equalizes the heat dissipated at each leg through construction of legs with equal resistance. In addition, in the event of failure of any electrical connection, no energy is delivered. This provides an additional safety feature over parallel wiring. As mentioned elsewhere, the electrical current may be AC or DC. AC may be delivered in the RF range as a safety measure additional to electrical isolation. DC may be used to allow a portable device powered by a battery pack or provide an energy source within the device itself.
  • FIG. 8A-8C illustrates variation of the legs 106 of the basket 104. As discussed above, the legs may, for example, comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material. The basket legs 106 may have a rectangular cross section in those variations where the legs 106 are formed from ribbons, or the legs 106 may have a circular cross section in variations where the legs 106 are formed from wires. Also, a leg 106 may be configured to have a non-axisymmetric cross-section. For example, the leg may have an oval or flat cross section as well. The legs 106 of a basket 104 need not all have similar cross sections. For instance, the cross section of each of the legs 106 in a basket 104 may be individually chosen to optimize such factors as the resilience of the basket 104, or to optimize energy transfer characteristics. An example of a cross section of a basket leg 106 is seen in FIG. 8A which illustrates a top view of a basket leg 106 that has a contoured shape 144. In this illustration, the energy exchange element is not shown in the figure for clarity. One of the purposes of such a contoured shape 144 is illustrated in FIG. 8B. When the basket (not shown) expands to its second state, leg 106 is configured to bend at or substantially near to points 146. A benefit of such a configuration is to allow a substantially parallel active surface as defined by the contour shape 144. FIG. 8C illustrates another variation of a leg 106. In this variation, the leg 106 has a region of increased diameter 148 in the case of round wire, or increased width or thickness in the case of rectangular or other non-axisymmetric wire. Such a region 106 could also be a flat wire with bumps or protrusions creating areas of increased width of the flat wire. This region 148 may, for example, provide a stop that assists in locating insulation, heat shrink, or other external covering around the leg 106. Also contemplated is a leg 106 that consists of a composite construction. In this variation, the leg 106 may comprise of differing materials in predetermined regions to control the bending of the leg 106 as the basket 104 expands, or the leg may be constructed of different materials to selectively control regions of deliver of energy on the leg.
  • FIG. 9A-9D illustrates another variation of the inventive device in which the expandable member comprises basket from a single piece or sheet of material. Such a configuration could comprise an etched, machined, laser cut, or otherwise manufactured piece of metal. FIG. 9A illustrates a partial view of a basket 104 formed from a single piece of material. The thickness of the material is, for example 0.005 inches but may vary as desired. The illustration of FIG. 9A shows the basket 104 prior to being wrapped about the Z direction as indicated. As shown, the legs 106 may be of varying length or they may be the same length 106 or a combination thereof. The basket 104 may have a distal portion 164 or basket head 164 which may be configured to facilitate construction of the device. For example, the basket head 164 may be notched 166 to obtain a desired shape as the basket is wrapped about the Z direction. FIG. 9B illustrates a variation of the basket head 165 being notched such that sections 165 of the material may be bent from the plane of the material to form tabs 165. Tabs 165 may be used to form mechanical joints with another part, such as a distal tip cap. FIG. 9C illustrates another variation of a basket 104 made from a single piece of material. In this example, the legs 106 of the basket 104 are bent in a direction orthogonal to the plane of the basket head 164. In this example, the distance between the ends of the legs 106 may be, for example, about 2.75 inches. FIG. 9D illustrates a variation of the proximal ends of the legs 106 of the basket 104. In this example, the proximal ends of the legs 106 may have features 168 which promote the structural integrity of the proximal joint (not shown) of the device. In this variation, the ends of the legs 106 have a saw-tooth design which improve the integrity of the proximal joint connecting the legs 106 to the elongated member. The variation of FIG. 9D also illustrates a proximal end of the leg 106 as having a radius, however, the end of the leg 106 may have other configurations as required. Also, the legs 106 may have a width of, for example, 0.012 inches and a separation of, for example, 0.016 inches. However, these dimensions may vary as needed.
  • FIG. 10 illustrates another variation of the inventive device 306 in which the expandable member comprises a balloon member 150. This variation of the device 306 includes electrodes 154 positioned on an exterior surface of the balloon member 150. The electrodes 154 may be connected to an energy source (not shown) by leads 156 extending through the balloon and through the lumen of an elongated member 102. The balloon member 150 may be filled with a fluid 152 such as saline or air to bring the electrodes 154 into contact with the airway wall 10. As noted above, the electrodes may also be resistance heating elements, RF electrodes, or another suitable element for conducting energy transfer with the airway. Also, a single electrode may continuously surround a circumference of a balloon 150, or a plurality of electrodes may be spaced at certain intervals to substantially surround the circumference of a balloon 150.
  • FIG. 11 illustrates another variation of the inventive device 308 in which the expandable member comprises a balloon member 150 in which a fluid 152 within the balloon member 150 is heated by a heat generating element 158. The heat generating elements 158 are illustrated in the shape of coils surrounding the shaft of the elongated member 102, however other types of heat generating elements (not shown) shapes may also be used. The heat generating elements 154 may be used as resistance heaters by application of an electric current to the heat generating elements. Alternatively, radio frequency or microwave energy may be applied to the heat generating elements 158 to heat fluid 152 within the balloon member 150. The fluid may be configured to optimize conductive heat transfer from the electrodes 158 to the exterior of the balloon member 150. The heat then passes from an exterior of the balloon 150 to the airway wall 10. Radio frequency or microwave energy may also be applied indirectly to the airway wall through the fluid and the balloon. In addition, hot fluid may be transmitted to the balloon member 150 from an external heating device for conductive heating of the airway tissue.
  • Another variation of the inventive device 310 is illustrated in FIG. 12 includes a plurality of energy transfer elements 162 positioned on pre-shaped tines 160. The pre-shaped tines 160 may be outwardly biased such that they expand from a first shape inside sheath 120 into a second expanded shape once advanced out of sheath 120. The tines 160 may also be configured so that they retract into a first state once withdrawn into a sheath 120. The pre-shaped tines 160 may be connected to an elongate member 102 which is positioned within a sheath 120. The pre-shaped tines 160 and the energy transfer elements 162 may be delivered through a delivery sheath 120 to a treatment site within the airways. When the pre-shaped tines 160 exit a distal end of the sheath 120, the pre-shaped tines 160 may bend outward until the energy transfer elements 162 come into contact with the airway walls for transfer of energy with the airway walls.
  • FIG. 13 illustrates a variation of the inventive device 314 in which a elongated member 102 is provided with a plurality of energy transfer elements 170 positioned on at least one inflatable balloon 172. The energy transfer elements 170 may be RF electrodes or resistance heating elements. The balloons 172 are inflated through the elongated member 102 to cause the energy transfer elements 170 to come into contact with the airway walls 10. The energy transfer elements 170 are preferably connected to the energy source (not shown) by conductive wires (not shown) which extend from the energy transfer elements 170 through or along the balloons 172 and through the elongated member 102 to the energy source. In the variation where the energy transfer elements 170 are RF electrodes, the electrodes 170 may be used in a bipolar mode without an external electrode. Alternatively, the inventive device 314 may be operated in a monopolar mode with an external electrode (not shown, see FIG. 4). Another variation of the invention includes using resistance heating elements as the energy transfer elements 170. The energy transfer elements 170 may be a single continuous circular element or there may be a plurality of elements 170 spaced around the balloons 172.
  • An alternative of the inventive device 316 of FIG. 14 includes an elongated member 102 having one or more grooves 174 in an exterior surface. Positioned within the grooves 174 are electrodes 176 for delivery of energy to the airway walls. Although the grooves 174 have been illustrated in a longitudinal pattern, the grooves may be easily configured in any desired pattern. Preferably, the inventive device 316 of FIG. 14 includes a biasing member (not shown) for biasing the elongated member 102 against an airway wall such that the electrodes 176 contact airway tissue. The biasing member (not shown) may be a spring element, an inflatable balloon element, or other biasing member. Alternatively, the biasing function may be performed by providing a preformed curve in the elongated member 102 which causes the device to curve into contact with the airway wall when extended from a delivery sheath (not shown).
  • FIG. 15 illustrates a variation of the inventive device 318 having one or more electrodes 178 connected to a distal end of an elongated tube 102. The electrodes 178 are supported between the distal end of the elongated tube 102 and a distal tip 180. A connecting shaft 182 supports the tip 180. Also connected between the distal end of the elongated member 102 and the distal tip 180 is a spring element 184 for biasing the electrodes 178 against a wall of the airway. The spring element 184 may have one end which slides in a track or groove in the elongated member 102 such that the spring 184 can flex to a variety of different positions depending on an internal diameter of the airway to be treated.
  • FIG. 16 illustrates an alternative of the inventive device 320 in which the one or more electrodes 186 are positioned on a body 188 secured to an end of an elongated member 102. In the FIG. 16 variation, the body 188 is illustrated as egg shaped, however, other body shapes may also be used. The electrodes 186 extend through holes 190 in the body 188 and along the body surface. A biasing member such as a spring element 184 is preferably provided on the body 188 for biasing the body with the electrodes 186 against the airway walls. Leads 192 are connected to the electrodes 186 and extend through the elongated member 102 to the energy source not shown.
  • FIGS. 17 and 18 illustrate embodiments of the invention 322, 324 in which electrodes 194 in the form of wires are positioned in one or more lumens 196 of an elongated member 102. Openings 198 are formed in side walls of the elongated member 102 to expose the electrodes 194 to the surrounding tissue. As shown in FIG. 17, the inventive device 322 may have multiple lumens 196 with electrodes 194 provided in each of the lumens 196. The side wall of the inventive device 322 is cut away to expose one or more of the electrodes 194 through a side wall opening 198. In FIG. 17, the opening 198 exposes two electrodes 194 positioned in adjacent lumens. The inventive device 322 may be provided with a biasing member as discussed above to bring the electrodes 195 of the device into contact with the airway wall.
  • Another variation of the inventive device 324 as shown in FIG. 18 includes an elongated member 102 which has an expandable loop shaped member 202 to allow the electrodes 194 to be exposed on opposite sides of the device 324 which contacts opposite sides of the airway. The resilience of the loop shaped member 202 causes the electrodes 194 to come into contact with the airway walls.
  • FIGS. 19 and 20 illustrate a further variation of the inventive device 326 having an expandable member 204 in a first non-expanded state and in a second expanded state. FIG. 19 illustrates the device as having one or more loop shaped electrodes 204 connected to an elongated member 102. In the unexpanded position shown in FIG. 19, the loop of the electrode 204 lies along the sides of a central core 206. A distal tip of the loop electrode 204 is secured to the core 206 and to a distal tip 208. The core 206 may be slidable in a lumen of the elongated member 102. Once the inventive device 326 has been positioned with the distal end in the airway to be treated, the electrode 204 is expanded by pulling the core 206 proximally with respect to the elongated member 102, as shown in FIG. 20. Alternatively, the electrode 204 or the core 206 may be spring biased to return to a configuration of FIG. 20 when a constraining force is removed. This constraining force may be applied by a delivery sheath or bronchoscope through which the inventive device 326 is inserted or by a releasable catch.
  • The treatment of the tissue in the airway walls by transfer of energy according to the present invention provides improved long term relief from asthma symptoms for some asthma sufferers. However, over time, some amount of smooth muscle or mucus gland cells which were not affected by an initial treatment may regenerate and treatment may have to be repeated after a period of time such as one or more months or years.
  • The airways which are treated with the device according to the present invention are preferably 1 mm in diameter or greater, more preferably 3 mm in diameter. The devices are preferably used to treat airways of the second to eighth generation, more preferably airways of the second to sixth generation.
  • Although the present invention has been described in detail with respect to devices for the treatment of airways in the lungs, it should be understood that the present invention may also be used for treatment of other body conduits. For example, the treatment system may be used for reducing smooth muscle and spasms of the esophagus of patients with achalasia or esophageal spasm, in coronary arteries of patients with Printzmetal's angina variant, for ureteral spasm, for urethral spasm, and irritable bowel disorders.
  • The devices and method describe herein provide a more effective and/or permanent treatment for asthma than the currently used bronchodilating drugs, drugs for reducing mucus secretion, and drugs for decreasing inflammation.
  • Moreover, the inventive device may also include a steering member configured to guide the device to a desired target location. For example, this steering member may deflect a distal tip of the device in a desired direction to navigate to a desired bronchi or bronchiole. Also contemplated it the use of the device with a vision system. Such a vision system may comprise a fiber optic cable which allows a user of the device to guide a distal tip of the device to its desired location. The vision system may include a CCD chip.
  • Also contemplated as the inventive device is the use of a power supply for providing energy as described above. The power supply provides the energy to be delivered to airway tissue via the energy transfer device. While the main goal of the power supply is to deliver enough energy to produce the desired effect, the power supply must also deliver the energy for a sufficient duration such that the effect persists. This is accomplished by a time setting which may be entered into the power supply memory by a user.
  • A power supply may also include circuitry for monitoring parameters of energy transfer: (for example, voltage, current, power, impedance, as well as temperature from the temperature sensing element), and use this information to control the amount of energy delivered.
  • A power supply may also include control modes for delivering energy safely and effectively. Energy may be delivered in open loop power control mode for a specific time duration. Energy may also be delivered in temperature control mode, with output power varied to maintain a certain temperature for a specific time duration. In the case of RF energy delivery via RF electrodes, the power supply may operate in impedance control mode.
  • In temperature control mode with RF electrodes described here, the power supply will operate at up to a 75° C. setting. The duration must be long enough to produce the desired effect, but as short as possible to allow treatment of all of the desired target airways within a lung. For example, 5 to 10 seconds per activation (while the device is stationary) is preferred. Shorter duration with higher temperature will also produce acceptable acute effect.
  • Using RF electrodes as described above in power control mode, power ranges of 10-15 W with durations of 3-5 seconds are preferred but may be varied. It should be noted that different device constructions utilize different parameter settings to achieve the desired effect. For example, while direct RF electrodes typically utilize temperatures up to 75° C. in temperature control mode, the resistively heated electrodes may utilize temperatures up to 90° C. Also, in addition to the control nodes specified above, the power supply may include control algorithms to limit excessive thermal damage to the airway tissue. For example, in order to stop delivery of energy in the event of contact between airway tissue and device legs having temperature sensing capabilities, an algorithm may be employed to shut down energy delivery if the sensed temperature does not rise by a certain number of degrees in a pre-specified amount of time after energy delivery begins. Another way to stop energy delivery includes shutting down a power supply if the temperature ramp is not within a predefined rage at any time during energy delivery. Other algorithms include shutting down a power supply if a maximum temperature setting is exceeded or shutting down a power supply if the sensed temperature suddenly changes, such a change includes either a drop or rise, this change may indicate failure of the temperature sensing element.
  • Moreover, a variation of the invention includes configuring each energy exchange element independently to provide selective energy transfer radially about the device. As discussed above, another variation of the invention includes providing feedback control to determine the impedance of the airway to determine the power required by a power supply. Again, as discussed above, the feedback control could also be used to determine the size of the airway in which the device is positioned.
  • Further details as to the use or other variation of the apparatus described herein may be drawn from the background which is intended to form part of the present invention. It is noted that this invention has been described and specific examples of the invention have been portrayed to convey a proper understanding of the invention. The use of such examples is not intended to limit the invention in any way. Additionally, to the extent that there are variations of the invention which are within the spirit of the disclosure and are equivalent to features found in the claims, it is the intent that the claims cover those variations as well. All equivalents are considered to be within the scope of the claimed invention, even those which may not have been set forth herein merely for the sake of brevity. Also, the various aspects of the invention described herein may be modified and/or used in combination with such other aspects also described to be part of the invention either explicitly or inherently to form other advantageous variations considered to be part of the invention covered by the claims which follow.

Claims (24)

1-78. (canceled)
79. An apparatus for delivering energy to airway tissue, comprising:
a flexible elongated body having a proximal portion and a distal portion;
a radially expandable electrode array including a rounded tip and at least four elongated flexible electrodes projecting from the distal portion of the body and longitudinally relative to the body, wherein each electrode has a proximal end attached to the distal portion of the elongated body, a distal end attached to the rounded tip, and an active region between the proximal and distal ends;
a first electric cable configured to be attached to one pole of an RF energy source and a first plurality of the electrodes, and a second cable configured to be attached to an opposite pole of the RF energy source and a second plurality of the electrodes, wherein the first and second cables provide RF energy to the first and second plurality of electrodes in a bipolar manner; and
a deployment member extending along the elongated body and attached to the rounded tip, wherein proximal movement of the deployment member flexes the electrodes such that the active regions move away from a longitudinal axis of the elongated body to contact the airway.
80. The apparatus of claim 79 wherein the electrodes are equally spaced apart from each other.
81. The apparatus of claim 79 wherein the active regions are approximately 10 mm long.
82. The apparatus of claim 79 wherein opposing active regions of the electrodes are diametrically spaced apart from each other by a distance of 10-12 mm in a fully flexed expanded state.
83. The apparatus of claim 79, further comprising a first thermocouple operatively coupled to one of the first plurality of electrodes and a second thermocouple operatively coupled to one of the second plurality of electrodes.
84. The apparatus of claim 79 wherein the electrodes are made from a flat wire positioned to flex so that the active regions move radially outward to a deployed configuration.
85. The apparatus of claim 79, further comprising a power source that provides RF energy in bipolar fields within airway tissue such that the electrodes reach a temperature of 65° C. for an activation time of at least 3 seconds.
86. The apparatus of claim 79, further comprising a power source that provides RF energy in bipolar fields within airway tissue such that the electrodes reach a temperature of 70° C. for an activation time of 2 seconds.
87. The apparatus of claim 79 wherein individual active regions form individual arches when moved radially outward.
88. An apparatus for delivering energy to airway tissue, comprising:
a flexible elongated body having a proximal portion and a distal portion;
a radially expandable electrode array including a rounded tip and at least four elongated flexible electrodes projecting longitudinally relative to the body, wherein each electrode has a proximal end attached to the distal portion of the elongated body, a distal end attached to the rounded tip, and an active region between the proximal and distal ends, and wherein the electrodes extend generally parallel to a longitudinal axis of the elongated body in a collapsed state and are configured to flex such that the active regions move radially outward relative to the longitudinal axis of the elongated body to contact the airway in an expanded state; and
a first electric cable configured to be attached to one pole of an RF energy source and a first plurality of the electrodes, and a second cable configured to be attached to an opposite pole of the RF energy source and a second plurality of the electrodes, wherein the first and second cables provide RF energy to the first and second plurality of electrodes in a bipolar manner such that airway smooth muscle tissue is debulked and the ability of the airway smooth muscle to contract is reduced.
89. The apparatus of claim 88 wherein the electrodes are equally spaced apart from each other.
90. The apparatus of claim 88 wherein the active regions are approximately 10 mm long.
91. The apparatus of claim 88 wherein opposing active regions of the electrodes are diametrically spaced apart from each other by a distance of 10-12 mm in a fully flexed expanded state.
92. The apparatus of claim 88, further comprising a first thermocouple operatively coupled to one of the first plurality of electrodes and a second thermocouple operatively coupled to one of the second plurality of electrodes.
93. The apparatus of claim 88 wherein the electrodes are made from a flat wire positioned to flex so that the active regions move radially outward to a deployed configuration.
94. The apparatus of claim 88, further comprising a power source that provides RF energy in bipolar fields within airway tissue such that the electrodes reach a temperature of 65° C. for an activation time of at least 3 seconds.
95. The apparatus of claim 88, further comprising a power source that provides RF energy in bipolar fields within airway tissue such that the electrodes reach a temperature of 70° C. for an activation time of 2 seconds.
96. The apparatus of claim 88 wherein individual active regions form individual arches when moved radially outward.
97. A method for treating asthma, comprising:
inserting a radially expandable electrode array into an airway in a lung of a patient, the radially expandable electrode array including at least four elongated flexible electrodes projecting from the distal portion of the body and longitudinally relative to the body, wherein each electrode has a proximal end attached to the distal portion of the elongated body, a distal end attached to a tip, and an active region between the proximal and distal ends;
flexing the electrodes such that the active regions move radially outward relative to a longitudinal axis of the elongated body and contact a wall of the airway, wherein individual active regions extend longitudinally along the wall of the airway; and
delivering RF energy to the wall of the airway via the electrodes in a bipolar manner such that airway smooth muscle tissue is debulked and the ability of the airway smooth muscle to contract is reduced.
98. The method of claim 97 wherein delivering the RF energy comprises heating the electrodes to at least 65° C. for at least 3 seconds and then terminating the RF energy.
99. The method of claim 97 wherein delivering the RF energy comprises heating the electrodes to approximately 70° C. for approximately 2 seconds and then terminating the RF energy.
100. The method of claim 97 wherein flexing the electrodes comprises moving the tip proximally, and wherein the method further comprises releasing the tip after terminating the RF energy such that the electrodes exert a longitudinal force that drives the tip distally and moves the active regions radially inward relative to the longitudinal axis of the elongated body.
101. The method of claim 97 wherein:
flexing the electrode comprises drawing a pull wire attached to the tip proximally such that the tip moves proximally;
delivering the RF energy comprises heating the electrodes to at least 65° C. for at least 3 seconds at a first treatment site in the airway and then terminating delivery of the RF energy;
releasing the pull wire after terminating delivery of the RF energy at the first treatment site, whereby the electrodes exert a longitudinal force that drives the tip distally and moves the active regions inward relative to the longitudinal axis of the elongated body;
moving the expandable electrode array proximally within the airway to a second treatment site;
pulling the pull wire proximally, which moves the tip proximally and causes the electrodes to flex such that the active regions move radially outward relative to the longitudinal axis of the elongated body and contact the wall of the airway at the second treatment site;
delivering the RF energy in a bipolar manner to the wall of the airway at the second treatment site such that the electrodes are heated to at least 65° C. for at least 3 seconds.
US12/206,591 1997-04-07 2008-09-08 Bipolar devices for modification of airways by transfer of energy Abandoned US20090069797A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/206,591 US20090069797A1 (en) 1997-04-07 2008-09-08 Bipolar devices for modification of airways by transfer of energy

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US08/833,550 US6273907B1 (en) 1997-04-07 1997-04-07 Bronchial stenter
US08/994,064 US6083255A (en) 1997-04-07 1997-12-19 Bronchial stenter
US09/003,750 US5972026A (en) 1997-04-07 1998-01-07 Bronchial stenter having diametrically adjustable electrodes
US9532398A 1998-06-10 1998-06-10
US09/224,937 US6200333B1 (en) 1997-04-07 1998-12-31 Bronchial stenter
US09/260,401 US6283988B1 (en) 1997-04-07 1999-03-01 Bronchial stenter having expandable electrodes
US09/296,040 US6411852B1 (en) 1997-04-07 1999-04-21 Modification of airways by application of energy
US09/349,715 US6488673B1 (en) 1997-04-07 1999-07-08 Method of increasing gas exchange of a lung
US09/436,455 US7425212B1 (en) 1998-06-10 1999-11-08 Devices for modification of airways by transfer of energy
US10/232,909 US7556624B2 (en) 1997-04-07 2002-08-30 Method of increasing gas exchange of a lung
US12/206,591 US20090069797A1 (en) 1997-04-07 2008-09-08 Bipolar devices for modification of airways by transfer of energy

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/436,455 Continuation US7425212B1 (en) 1997-04-07 1999-11-08 Devices for modification of airways by transfer of energy

Publications (1)

Publication Number Publication Date
US20090069797A1 true US20090069797A1 (en) 2009-03-12

Family

ID=39743202

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/436,455 Expired - Fee Related US7425212B1 (en) 1997-04-07 1999-11-08 Devices for modification of airways by transfer of energy
US12/206,591 Abandoned US20090069797A1 (en) 1997-04-07 2008-09-08 Bipolar devices for modification of airways by transfer of energy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/436,455 Expired - Fee Related US7425212B1 (en) 1997-04-07 1999-11-08 Devices for modification of airways by transfer of energy

Country Status (1)

Country Link
US (2) US7425212B1 (en)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060137698A1 (en) * 1998-06-10 2006-06-29 Asthmatx, Inc. Methods for treating airways
US20060247619A1 (en) * 2004-11-05 2006-11-02 Asthmatx, Inc. Medical device with procedure improvement features
US20070100390A1 (en) * 2000-10-17 2007-05-03 Asthmatx, Inc. Modification of airways by application of energy
US20070106296A1 (en) * 1997-04-07 2007-05-10 Asthmatx, Inc. Expandable electode devices and methods of treating bronchial tubes
US20070106292A1 (en) * 2004-11-05 2007-05-10 Asthmatx, Inc. Energy delivery devices and methods
US20070123961A1 (en) * 2004-11-12 2007-05-31 Asthmax, Inc. Energy delivery and illumination devices and methods
US20070123958A1 (en) * 1998-06-10 2007-05-31 Asthmatx, Inc. Apparatus for treating airways in the lung
US20090143705A1 (en) * 1997-04-07 2009-06-04 Asthmatx, Inc. Modification of airways by application of ultrasound energy
US20100160906A1 (en) * 2008-12-23 2010-06-24 Asthmatx, Inc. Expandable energy delivery devices having flexible conductive elements and associated systems and methods
US7837679B2 (en) 2000-10-17 2010-11-23 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US7931647B2 (en) 2006-10-20 2011-04-26 Asthmatx, Inc. Method of delivering energy to a lung airway using markers
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8172827B2 (en) 2003-05-13 2012-05-08 Innovative Pulmonary Solutions, Inc. Apparatus for treating asthma using neurotoxin
US20120116378A1 (en) * 2010-04-26 2012-05-10 Minerva Surgical, Inc. Endometrial ablation with a device that conforms to symmetric or asymmetric uterine cavities
US8235983B2 (en) * 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US8443810B2 (en) 1998-06-10 2013-05-21 Asthmatx, Inc. Methods of reducing mucus in airways
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US20150265458A1 (en) * 2014-02-21 2015-09-24 Circuit Therapeutics, Inc. System and method for therapeutic management of unproductive cough
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9283374B2 (en) 2012-11-05 2016-03-15 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9592086B2 (en) 2012-07-24 2017-03-14 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9770293B2 (en) 2012-06-04 2017-09-26 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
CN107374725A (en) * 2017-08-31 2017-11-24 苏州信迈医疗器械有限公司 A kind of multipole ablating device
US10478247B2 (en) 2013-08-09 2019-11-19 Boston Scientific Scimed, Inc. Expandable catheter and related methods of manufacture and use
CN111227929A (en) * 2018-11-29 2020-06-05 上海安臻医疗科技有限公司 Adjustable bronchus thermoforming pipe
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10858735B2 (en) 2014-09-10 2020-12-08 Applied Materials, Inc. Alignment systems employing actuators providing relative displacement between lid assemblies of process chambers and substrates, and related methods
US20210038289A1 (en) * 2019-08-05 2021-02-11 Karl Storz Se & Co. Kg Endoscopic device

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425212B1 (en) * 1998-06-10 2008-09-16 Asthmatx, Inc. Devices for modification of airways by transfer of energy
US20060095032A1 (en) * 1999-11-16 2006-05-04 Jerome Jackson Methods and systems for determining physiologic characteristics for treatment of the esophagus
US6551310B1 (en) 1999-11-16 2003-04-22 Robert A. Ganz System and method of treating abnormal tissue in the human esophagus
US20040215235A1 (en) 1999-11-16 2004-10-28 Barrx, Inc. Methods and systems for determining physiologic characteristics for treatment of the esophagus
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US6752767B2 (en) 2002-04-16 2004-06-22 Vivant Medical, Inc. Localization element with energized tip
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
DE202004021943U1 (en) 2003-09-12 2013-05-13 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US7150745B2 (en) 2004-01-09 2006-12-19 Barrx Medical, Inc. Devices and methods for treatment of luminal tissue
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
CN101115448B (en) 2004-11-16 2010-05-12 罗伯特·L·巴里 Device and method for lung treatment
EP1819304B1 (en) 2004-12-09 2023-01-25 Twelve, Inc. Aortic valve repair
EP3045110B1 (en) 2005-03-28 2019-07-31 Vessix Vascular, Inc. Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues
EP1874211B1 (en) 2005-04-21 2017-05-31 Boston Scientific Scimed, Inc. Control devices for energy delivery
US8702694B2 (en) 2005-11-23 2014-04-22 Covidien Lp Auto-aligning ablating device and method of use
US7997278B2 (en) 2005-11-23 2011-08-16 Barrx Medical, Inc. Precision ablating method
US7959627B2 (en) * 2005-11-23 2011-06-14 Barrx Medical, Inc. Precision ablating device
WO2007126949A1 (en) * 2006-03-31 2007-11-08 Wilson-Cook Medical, Inc. Electrosurgical cutting device
US9814519B2 (en) * 2006-04-20 2017-11-14 Boston Scientific Scimed, Inc. Ablation probe with ribbed insulated sheath
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
WO2008049087A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
EP2954868A1 (en) 2006-10-18 2015-12-16 Vessix Vascular, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
WO2008137757A1 (en) 2007-05-04 2008-11-13 Barrx Medical, Inc. Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US8784338B2 (en) 2007-06-22 2014-07-22 Covidien Lp Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
KR101547931B1 (en) 2007-07-06 2015-08-28 코비디엔 엘피 Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding
WO2009009443A1 (en) * 2007-07-06 2009-01-15 Barrx Medical, Inc. Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation
US8646460B2 (en) 2007-07-30 2014-02-11 Covidien Lp Cleaning device and methods
US8273012B2 (en) * 2007-07-30 2012-09-25 Tyco Healthcare Group, Lp Cleaning device and methods
US8322335B2 (en) 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US8292880B2 (en) 2007-11-27 2012-10-23 Vivant Medical, Inc. Targeted cooling of deployable microwave antenna
EP2334365B1 (en) * 2008-09-22 2016-10-26 Boston Scientific Scimed, Inc. Biasing a catheter balloon
EP2355737B1 (en) 2008-11-17 2021-08-11 Boston Scientific Scimed, Inc. Selective accumulation of energy without knowledge of tissue topography
WO2010080886A1 (en) 2009-01-09 2010-07-15 Recor Medical, Inc. Methods and apparatus for treatment of mitral valve in insufficiency
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
US8323275B2 (en) 2009-06-19 2012-12-04 Vivant Medical, Inc. Laparoscopic port with microwave rectifier
US8672938B2 (en) * 2009-07-23 2014-03-18 Covidien Lp Active cooling system and apparatus for controlling temperature of a fluid used during treatment of biological tissue
US9113927B2 (en) 2010-01-29 2015-08-25 Covidien Lp Apparatus and methods of use for treating blood vessels
JP2013523318A (en) 2010-04-09 2013-06-17 べシックス・バスキュラー・インコーポレイテッド Power generation and control equipment for tissue treatment
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
US10278774B2 (en) 2011-03-18 2019-05-07 Covidien Lp Selectively expandable operative element support structure and methods of use
KR20130131471A (en) 2011-04-08 2013-12-03 코비디엔 엘피 Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
EP2701623B1 (en) 2011-04-25 2016-08-17 Medtronic Ardian Luxembourg S.à.r.l. Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US9579030B2 (en) 2011-07-20 2017-02-28 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
CN103813829B (en) 2011-07-22 2016-05-18 波士顿科学西美德公司 There is the neuromodulation system of the neuromodulation element that can be positioned in spiral guiding piece
US9186210B2 (en) 2011-10-10 2015-11-17 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
WO2013059202A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
US9162046B2 (en) 2011-10-18 2015-10-20 Boston Scientific Scimed, Inc. Deflectable medical devices
US9486243B2 (en) 2011-11-08 2016-11-08 Covidien Lp Systems and methods for treatment of premenstrual dysphoric disorders
EP3366250A1 (en) 2011-11-08 2018-08-29 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
JP6130397B2 (en) 2011-12-23 2017-05-17 べシックス・バスキュラー・インコーポレイテッド Device for remodeling tissue in or adjacent to a body passage
WO2013101452A1 (en) 2011-12-28 2013-07-04 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US9950188B2 (en) 2012-05-31 2018-04-24 Color Seven Co., Ltd. Apparatus for relaxing smooth muscles of human body
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
WO2014043687A2 (en) 2012-09-17 2014-03-20 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
US9668802B2 (en) 2012-10-02 2017-06-06 Covidien Lp Devices and methods for optical detection of tissue contact
US9522033B2 (en) 2012-10-02 2016-12-20 Covidien Lp Devices and methods for optical detection of tissue contact
EP2906135A2 (en) 2012-10-10 2015-08-19 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
US20140257130A1 (en) * 2013-03-11 2014-09-11 Boston Scientific Scimed, Inc. Powered pull wire design for ablation catheters
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
JP6220044B2 (en) 2013-03-15 2017-10-25 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation
WO2014149690A2 (en) 2013-03-15 2014-09-25 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
CN105473091B (en) 2013-06-21 2020-01-21 波士顿科学国际有限公司 Renal denervation balloon catheter with co-movable electrode supports
US10022182B2 (en) 2013-06-21 2018-07-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
EP3010435A1 (en) * 2013-06-21 2016-04-27 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
WO2015002787A1 (en) 2013-07-01 2015-01-08 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
WO2015006573A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
US9925001B2 (en) 2013-07-19 2018-03-27 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
CN105392435B (en) 2013-07-22 2018-11-09 波士顿科学国际有限公司 Renal nerve ablation catheter with twisting sacculus
US10342609B2 (en) 2013-07-22 2019-07-09 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
EP4049605A1 (en) 2013-08-22 2022-08-31 Boston Scientific Scimed Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
WO2015035047A1 (en) 2013-09-04 2015-03-12 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
EP3043733A1 (en) 2013-09-13 2016-07-20 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US9782211B2 (en) 2013-10-01 2017-10-10 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
WO2015057584A1 (en) 2013-10-15 2015-04-23 Boston Scientific Scimed, Inc. Medical device balloon
EP3057521B1 (en) 2013-10-18 2020-03-25 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires
EP3060153A1 (en) 2013-10-25 2016-08-31 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
CN105899157B (en) 2014-01-06 2019-08-09 波士顿科学国际有限公司 Tear-proof flexible circuit assembly
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
EP3102136B1 (en) 2014-02-04 2018-06-27 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US10398488B2 (en) * 2014-09-04 2019-09-03 Medtronic Cryocath Lp Cryoadhesive device for left atrial appendage occlusion
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
USD845467S1 (en) 2017-09-17 2019-04-09 Uptake Medical Technology Inc. Hand-piece for medical ablation catheter
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
US11490946B2 (en) 2017-12-13 2022-11-08 Uptake Medical Technology Inc. Vapor ablation handpiece
US11457977B2 (en) * 2019-02-08 2022-10-04 Shanghai Golden Leaf Medtech Co., Ltd. Method for treating diabetes, diabetes-associated condition or disorder, or symptoms thereof
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease

Citations (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1216183A (en) * 1916-09-18 1917-02-13 Charles M Swingle Electrotherapeutic rejuvenator.
US3597612A (en) * 1969-01-27 1971-08-03 Atomic Energy Commission Power-pulse monitoring probe
US4502490A (en) * 1980-10-28 1985-03-05 Antec Systems Limited Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions
US4503855A (en) * 1981-12-31 1985-03-12 Harald Maslanka High frequency surgical snare electrode
US4512762A (en) * 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4643186A (en) * 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US4646737A (en) * 1983-06-13 1987-03-03 Laserscope, Inc. Localized heat applying medical device
US4739759A (en) * 1985-02-26 1988-04-26 Concept, Inc. Microprocessor controlled electrosurgical generator
US4817586A (en) * 1987-11-24 1989-04-04 Nimbus Medical, Inc. Percutaneous bloom pump with mixed-flow output
US4895557A (en) * 1987-12-07 1990-01-23 Nimbus Medical, Inc. Drive mechanism for powering intravascular blood pumps
US4906229A (en) * 1988-05-03 1990-03-06 Nimbus Medical, Inc. High-frequency transvalvular axisymmetric blood pump
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4908012A (en) * 1988-08-08 1990-03-13 Nimbus Medical, Inc. Chronic ventricular assist system
US4985014A (en) * 1989-07-11 1991-01-15 Orejola Wilmo C Ventricular venting loop
US4991603A (en) * 1989-10-30 1991-02-12 Siemens-Pacesetter, Inc. Transvenously placed defibrillation leads via an inferior vena cava access site and method of use
US5009936A (en) * 1988-09-02 1991-04-23 Nissan Motor Co., Ltd. Method for forming tranparent multilayers
US5009636A (en) * 1989-12-06 1991-04-23 The Kendall Company Dual-lumen catheter apparatus and method
US5010892A (en) * 1988-05-04 1991-04-30 Triangle Research And Development Corp. Body lumen measuring instrument
US5078716A (en) * 1990-05-11 1992-01-07 Doll Larry F Electrosurgical apparatus for resecting abnormal protruding growth
US5105826A (en) * 1990-10-26 1992-04-21 Medtronic, Inc. Implantable defibrillation electrode and method of manufacture
US5106360A (en) * 1987-09-17 1992-04-21 Olympus Optical Co., Ltd. Thermotherapeutic apparatus
US5107830A (en) * 1987-02-21 1992-04-28 University Of Manitoba Lung ventilator device
US5188602A (en) * 1990-07-12 1993-02-23 Interventional Thermodynamics, Inc. Method and device for delivering heat to hollow body organs
US5277201A (en) * 1992-05-01 1994-01-11 Vesta Medical, Inc. Endometrial ablation apparatus and method
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5376094A (en) * 1993-08-19 1994-12-27 Boston Scientific Corporation Improved actuating handle with pulley system for providing mechanical advantage to a surgical working element
WO1995002370A2 (en) * 1993-07-15 1995-01-26 Aws Shakir Mustafa Salim Tunnelling catheter
US5393207A (en) * 1993-01-21 1995-02-28 Nimbus, Inc. Blood pump with disposable rotor assembly
US5400778A (en) * 1990-06-18 1995-03-28 Siemens-Elema Ab Method and device for reduction of rebreathing of gas from dead space
US5496271A (en) * 1990-09-14 1996-03-05 American Medical Systems, Inc. Combined hyperthermia and dilation catheter
US5496312A (en) * 1993-10-07 1996-03-05 Valleylab Inc. Impedance and temperature generator control
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5507791A (en) * 1993-08-31 1996-04-16 Sit'ko; Sergei P. Microwave resonance therapy
US5599345A (en) * 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5623940A (en) * 1994-08-02 1997-04-29 S.L.T. Japan Co., Ltd. Catheter apparatus with a sensor
WO1997032532A1 (en) * 1996-03-05 1997-09-12 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
US5707336A (en) * 1995-01-09 1998-01-13 Cardassist Incorporated Ventricular assist device
US5707218A (en) * 1995-04-19 1998-01-13 Nimbus, Inc. Implantable electric axial-flow blood pump with blood cooled bearing
US5727569A (en) * 1996-02-20 1998-03-17 Cardiothoracic Systems, Inc. Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery
US5728094A (en) * 1996-02-23 1998-03-17 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5730704A (en) * 1992-02-24 1998-03-24 Avitall; Boaz Loop electrode array mapping and ablation catheter for cardiac chambers
US5735846A (en) * 1994-06-27 1998-04-07 Ep Technologies, Inc. Systems and methods for ablating body tissue using predicted maximum tissue temperature
US5741248A (en) * 1995-06-07 1998-04-21 Temple University-Of The Commonwealth System Of Higher Education Fluorochemical liquid augmented cryosurgery
WO1999003413A1 (en) * 1997-07-17 1999-01-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
US5873852A (en) * 1995-07-10 1999-02-23 Interventional Technologies Device for injecting fluid into a wall of a blood vessel
US5876340A (en) * 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5876399A (en) * 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US5891135A (en) * 1996-01-19 1999-04-06 Ep Technologies, Inc. Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures
US5891136A (en) * 1996-01-19 1999-04-06 Ep Technologies, Inc. Expandable-collapsible mesh electrode structures
US5891138A (en) * 1997-08-11 1999-04-06 Irvine Biomedical, Inc. Catheter system having parallel electrodes
US5893847A (en) * 1993-03-16 1999-04-13 Ep Technologies, Inc. Multiple electrode support structures with slotted hub and hoop spline elements
US6014579A (en) * 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
US6023638A (en) * 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6029091A (en) * 1998-07-09 2000-02-22 Irvine Biomedical, Inc. Catheter system having lattice electrodes
US6033397A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6036689A (en) * 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
US6039731A (en) * 1995-06-09 2000-03-21 Engineering & Research Associates, Inc. Apparatus and method for determining the extent of ablation
US6045549A (en) * 1997-09-30 2000-04-04 Somnus Medical Technologies, Inc. Tissue ablation apparatus and device for use therein and method
US6050992A (en) * 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US6053909A (en) * 1998-03-27 2000-04-25 Shadduck; John H. Ionothermal delivery system and technique for medical procedures
US6179833B1 (en) * 1995-06-09 2001-01-30 Engineering & Research Associates, Inc. Apparatus for thermal ablation
US6183468B1 (en) * 1998-09-10 2001-02-06 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6200311B1 (en) * 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6200332B1 (en) * 1999-07-09 2001-03-13 Ceramoptec Industries, Inc. Device and method for underskin laser treatments
US6210367B1 (en) * 1995-09-06 2001-04-03 Microwave Medical Systems, Inc. Intracorporeal microwave warming method and apparatus
US6212433B1 (en) * 1998-07-28 2001-04-03 Radiotherapeutics Corporation Method for treating tumors near the surface of an organ
US6214002B1 (en) * 1994-10-07 2001-04-10 Ep Technologies, Inc. Structures and methods for deploying electrode elements
US6216043B1 (en) * 1994-03-04 2001-04-10 Ep Technologies, Inc. Asymmetric multiple electrode support structures
US6217576B1 (en) * 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US6338727B1 (en) * 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6346104B2 (en) * 1996-04-30 2002-02-12 Western Sydney Area Health Service System for simultaneous unipolar multi-electrode ablation
US6355031B1 (en) * 1998-02-19 2002-03-12 Curon Medical, Inc. Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter
US6370644B1 (en) * 1998-04-07 2002-04-09 Micron Technology, Inc. Device for blocking bus transactions during reset
US6379352B1 (en) * 1992-09-29 2002-04-30 Ep Technologies, Inc. Large surface cardiac ablation catherter that assumes a low profile during introduction into the heart
US6514246B1 (en) * 1993-10-14 2003-02-04 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US6526320B2 (en) * 1998-11-16 2003-02-25 United States Surgical Corporation Apparatus for thermal treatment of tissue
US6529756B1 (en) * 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US20030050631A1 (en) * 2000-12-29 2003-03-13 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US20030065371A1 (en) * 2001-09-28 2003-04-03 Shutaro Satake Radiofrequency thermal balloon catheter
US6544226B1 (en) * 2000-03-13 2003-04-08 Curon Medical, Inc. Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body
US20030069570A1 (en) * 1999-10-02 2003-04-10 Witzel Thomas H. Methods for repairing mitral valve annulus percutaneously
US6547788B1 (en) * 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
US6673068B1 (en) * 2000-04-12 2004-01-06 Afx, Inc. Electrode arrangement for use in a medical instrument
US6689693B2 (en) * 2000-08-30 2004-02-10 Micron Technology, Inc. Methods for utilization of disappearing silicon hard mask for fabrication of semiconductor structures
US6692492B2 (en) * 2001-11-28 2004-02-17 Cardiac Pacemaker, Inc. Dielectric-coated ablation electrode having a non-coated window with thermal sensors
US20040031494A1 (en) * 1998-06-10 2004-02-19 Broncus Technologies, Inc. Methods of treating asthma
US6699243B2 (en) * 2001-09-19 2004-03-02 Curon Medical, Inc. Devices, systems and methods for treating tissue regions of the body
US6714822B2 (en) * 1998-04-30 2004-03-30 Medtronic, Inc. Apparatus and method for expanding a stimulation lead body in situ
US6723091B2 (en) * 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US6837888B2 (en) * 1995-06-07 2005-01-04 Arthrocare Corporation Electrosurgical probe with movable return electrode and methods related thereto
US6840243B2 (en) * 2000-03-04 2005-01-11 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US6849073B2 (en) * 1998-07-07 2005-02-01 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6852110B2 (en) * 2002-08-01 2005-02-08 Solarant Medical, Inc. Needle deployment for temperature sensing from an electrode
US6852091B2 (en) * 1992-08-12 2005-02-08 Medtronic Vidamed, Inc. Medical probe device and method
US6866662B2 (en) * 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6881213B2 (en) * 2002-06-28 2005-04-19 Ethicon, Inc. Device and method to expand treatment array
US20060062808A1 (en) * 2004-09-18 2006-03-23 Asthmatx, Inc. Inactivation of smooth muscle tissue
US7186251B2 (en) * 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US20080004596A1 (en) * 2006-05-25 2008-01-03 Palo Alto Institute Delivery of agents by microneedle catheter
US7425212B1 (en) * 1998-06-10 2008-09-16 Asthmatx, Inc. Devices for modification of airways by transfer of energy
US20090018538A1 (en) * 2007-07-12 2009-01-15 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US20090030477A1 (en) * 2007-07-24 2009-01-29 Asthmatx, Inc. System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices
US20090043301A1 (en) * 2007-08-09 2009-02-12 Asthmatx, Inc. Monopolar energy delivery devices and methods for controlling current density in tissue

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1155169A (en) 1914-11-28 1915-09-28 John Starkweather Surgical instrument.
US1207479A (en) 1915-03-05 1916-12-05 Holger Bisgaard Self-retaining gatheter.
US2072346A (en) 1934-10-04 1937-03-02 Ward R Smith Drainage tube
US3568659A (en) 1968-09-24 1971-03-09 James N Karnegis Disposable percutaneous intracardiac pump and method of pumping blood
US3667476A (en) 1970-04-27 1972-06-06 Bio Data Corp Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature
US3692029A (en) 1971-05-03 1972-09-19 Edwin Lloyd Adair Retention catheter and suprapubic shunt
US4565200A (en) 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
JPS57168656A (en) 1981-04-10 1982-10-18 Medos Kenkyusho Kk Endoscope laser coagulator
US4706688A (en) 1981-05-18 1987-11-17 Don Michael T Anthony Non-invasive cardiac device
US4612934A (en) 1981-06-30 1986-09-23 Borkan William N Non-invasive multiprogrammable tissue stimulator
US4584998A (en) 1981-09-11 1986-04-29 Mallinckrodt, Inc. Multi-purpose tracheal tube
US4567882A (en) 1982-12-06 1986-02-04 Vanderbilt University Method for locating the illuminated tip of an endotracheal tube
US4522212A (en) 1983-11-14 1985-06-11 Mansfield Scientific, Inc. Endocardial electrode
FR2561929B1 (en) 1984-03-27 1989-02-03 Atesys IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION
JPS6148350A (en) 1984-08-15 1986-03-10 オリンパス光学工業株式会社 Medical laser apparatus
US5019075A (en) 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
EP0189329A3 (en) * 1985-01-25 1987-06-03 Robert E. Fischell A tunneling catheter system for transluminal arterial angioplasty
US4862886A (en) 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4976709A (en) 1988-12-15 1990-12-11 Sand Bruce J Method for collagen treatment
US4827935A (en) 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
US4709698A (en) 1986-05-14 1987-12-01 Thomas J. Fogarty Heatable dilation catheter
US5215103A (en) 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5231995A (en) 1986-11-14 1993-08-03 Desai Jawahar M Method for catheter mapping and ablation
US4802492A (en) 1987-03-11 1989-02-07 National Jewish Center For Immunology And Respiratory Medicine Method for determining respiratory function
US5588432A (en) 1988-03-21 1996-12-31 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US4920978A (en) 1988-08-31 1990-05-01 Triangle Research And Development Corporation Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia
US5191883A (en) 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US4955377A (en) 1988-10-28 1990-09-11 Lennox Charles D Device and method for heating tissue in a patient's body
US5433730A (en) 1989-05-03 1995-07-18 Intermedics, Inc. Conductive pouch electrode for defibrillation
US5152286A (en) 1989-05-08 1992-10-06 Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" Method of microwave resonance therapy and device therefor
US5074860A (en) * 1989-06-09 1991-12-24 Heraeus Lasersonics, Inc. Apparatus for directing 10.6 micron laser radiation to a tissue site
US5084044A (en) 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5562608A (en) 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5057105A (en) 1989-08-28 1991-10-15 The University Of Kansas Med Center Hot tip catheter assembly
JP2984056B2 (en) 1989-09-08 1999-11-29 ボストン サイエンティフィック コーポレイション Physiological low pressure angioplasty
US5100388A (en) 1989-09-15 1992-03-31 Interventional Thermodynamics, Inc. Method and device for thermal ablation of hollow body organs
US5117828A (en) 1989-09-25 1992-06-02 Arzco Medical Electronics, Inc. Expandable esophageal catheter
US5254088A (en) * 1990-02-02 1993-10-19 Ep Technologies, Inc. Catheter steering mechanism
US5549559A (en) 1990-03-22 1996-08-27 Argomed Ltd. Thermal treatment apparatus
US5096916A (en) 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5056519A (en) 1990-05-14 1991-10-15 Vince Dennis J Unilateral diaphragmatic pacer
US5265604A (en) 1990-05-14 1993-11-30 Vince Dennis J Demand - diaphragmatic pacing (skeletal muscle pressure modified)
US5103804A (en) 1990-07-03 1992-04-14 Boston Scientific Corporation Expandable tip hemostatic probes and the like
US5135517A (en) 1990-07-19 1992-08-04 Catheter Research, Inc. Expandable tube-positioning apparatus
US5100423A (en) 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5170803A (en) 1990-09-28 1992-12-15 Brunswick Biomedical Technologies, Inc. Esophageal displacement electrode
US5053033A (en) 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
US5174288A (en) 1990-11-30 1992-12-29 Medtronic, Inc. Method and apparatus for cardiac defibrillation
US5465717A (en) 1991-02-15 1995-11-14 Cardiac Pathways Corporation Apparatus and Method for ventricular mapping and ablation
US5415166A (en) 1991-02-15 1995-05-16 Cardiac Pathways Corporation Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5116864A (en) 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
JPH06507097A (en) 1991-04-10 1994-08-11 ビーティージー・インターナショナル・インコーポレーテッド Defibrillator, temporary pacer catheter, and its implantation method
US5255678A (en) 1991-06-21 1993-10-26 Ecole Polytechnique Mapping electrode balloon
US5383917A (en) 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5540681A (en) 1992-04-10 1996-07-30 Medtronic Cardiorhythm Method and system for radiofrequency ablation of tissue
US5269758A (en) 1992-04-29 1993-12-14 Taheri Syde A Intravascular catheter and method for treatment of hypothermia
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5255679A (en) 1992-06-02 1993-10-26 Cardiac Pathways Corporation Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method
US5281218A (en) 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5411025A (en) 1992-06-30 1995-05-02 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array
GB9219102D0 (en) 1992-09-09 1992-10-21 Fairfax Andrew J Flowmeters
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5309910A (en) * 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5293869A (en) 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5471982A (en) 1992-09-29 1995-12-05 Ep Technologies, Inc. Cardiac mapping and ablation systems
DE669839T1 (en) 1992-10-01 1996-10-10 Cardiac Pacemakers Inc STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES.
US5431696A (en) 1992-10-13 1995-07-11 Atlee, Iii; John L. Esophageal probe for transeophageal cardiac stimulation
US5545161A (en) 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US5348554A (en) 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5256141A (en) 1992-12-22 1993-10-26 Nelson Gencheff Biological material deployment method and apparatus
US5725525A (en) * 1993-03-16 1998-03-10 Ep Technologies, Inc. Multiple electrode support structures with integral hub and spline elements
CA2158453C (en) * 1993-03-16 1999-11-16 Thomas F. Kordis Multiple electrode support structures
US5417687A (en) 1993-04-30 1995-05-23 Medical Scientific, Inc. Bipolar electrosurgical trocar
US5456667A (en) 1993-05-20 1995-10-10 Advanced Cardiovascular Systems, Inc. Temporary stenting catheter with one-piece expandable segment
US5396887A (en) 1993-09-23 1995-03-14 Cardiac Pathways Corporation Apparatus and method for detecting contact pressure
US5607462A (en) 1993-09-24 1997-03-04 Cardiac Pathways Corporation Catheter assembly, catheter and multi-catheter introducer for use therewith
US5626618A (en) 1993-09-24 1997-05-06 The Ohio State University Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring
US5415656A (en) 1993-09-28 1995-05-16 American Medical Systems, Inc. Electrosurgical apparatus
US5400783A (en) 1993-10-12 1995-03-28 Cardiac Pathways Corporation Endocardial mapping apparatus with rotatable arm and method
US5545193A (en) 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5423812A (en) 1994-01-31 1995-06-13 Ellman; Alan G. Electrosurgical stripping electrode for palatopharynx tissue
US5394880A (en) 1994-03-17 1995-03-07 Atlee, Iii; John L. Esophageal stethoscope
US5598848A (en) 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5478309A (en) 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5681308A (en) 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5680860A (en) 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US5454782A (en) 1994-08-11 1995-10-03 Perkins; Rodney C. Translumenal circumferential energy delivery device
US5549655A (en) 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US5522862A (en) 1994-09-21 1996-06-04 Medtronic, Inc. Method and apparatus for treating obstructive sleep apnea
US5836947A (en) * 1994-10-07 1998-11-17 Ep Technologies, Inc. Flexible structures having movable splines for supporting electrode elements
US5899882A (en) * 1994-10-27 1999-05-04 Novoste Corporation Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient
US5605157A (en) 1995-02-17 1997-02-25 Ep Technologies, Inc. Systems and methods for filtering signals derived from biological events
US5595183A (en) 1995-02-17 1997-01-21 Ep Technologies, Inc. Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
US5601088A (en) 1995-02-17 1997-02-11 Ep Technologies, Inc. Systems and methods for filtering artifacts from composite signals
US5630425A (en) 1995-02-17 1997-05-20 Ep Technologies, Inc. Systems and methods for adaptive filtering artifacts from composite signals
US5620438A (en) 1995-04-20 1997-04-15 Angiomedics Ii Incorporated Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis
US5678535A (en) 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
US5607419A (en) 1995-04-24 1997-03-04 Angiomedics Ii Inc. Method and apparatus for treating vessel wall with UV radiation following angioplasty
US5624439A (en) 1995-08-18 1997-04-29 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5846238A (en) * 1996-01-19 1998-12-08 Ep Technologies, Inc. Expandable-collapsible electrode structures with distal end steering or manipulation
US5699799A (en) 1996-03-26 1997-12-23 Siemens Corporate Research, Inc. Automatic determination of the curved axis of a 3-D tube-shaped object in image volume
US6056769A (en) * 1997-02-11 2000-05-02 Biointerventional Corporation Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method
US6071281A (en) * 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same

Patent Citations (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1216183A (en) * 1916-09-18 1917-02-13 Charles M Swingle Electrotherapeutic rejuvenator.
US3597612A (en) * 1969-01-27 1971-08-03 Atomic Energy Commission Power-pulse monitoring probe
US4502490A (en) * 1980-10-28 1985-03-05 Antec Systems Limited Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions
US4503855A (en) * 1981-12-31 1985-03-12 Harald Maslanka High frequency surgical snare electrode
US4512762A (en) * 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4646737A (en) * 1983-06-13 1987-03-03 Laserscope, Inc. Localized heat applying medical device
US4739759A (en) * 1985-02-26 1988-04-26 Concept, Inc. Microprocessor controlled electrosurgical generator
US4643186A (en) * 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US5107830A (en) * 1987-02-21 1992-04-28 University Of Manitoba Lung ventilator device
US5106360A (en) * 1987-09-17 1992-04-21 Olympus Optical Co., Ltd. Thermotherapeutic apparatus
US4817586A (en) * 1987-11-24 1989-04-04 Nimbus Medical, Inc. Percutaneous bloom pump with mixed-flow output
US4895557A (en) * 1987-12-07 1990-01-23 Nimbus Medical, Inc. Drive mechanism for powering intravascular blood pumps
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4906229A (en) * 1988-05-03 1990-03-06 Nimbus Medical, Inc. High-frequency transvalvular axisymmetric blood pump
US5010892A (en) * 1988-05-04 1991-04-30 Triangle Research And Development Corp. Body lumen measuring instrument
US4908012A (en) * 1988-08-08 1990-03-13 Nimbus Medical, Inc. Chronic ventricular assist system
US5009936A (en) * 1988-09-02 1991-04-23 Nissan Motor Co., Ltd. Method for forming tranparent multilayers
US4985014A (en) * 1989-07-11 1991-01-15 Orejola Wilmo C Ventricular venting loop
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US4991603A (en) * 1989-10-30 1991-02-12 Siemens-Pacesetter, Inc. Transvenously placed defibrillation leads via an inferior vena cava access site and method of use
US5009636A (en) * 1989-12-06 1991-04-23 The Kendall Company Dual-lumen catheter apparatus and method
US5078716A (en) * 1990-05-11 1992-01-07 Doll Larry F Electrosurgical apparatus for resecting abnormal protruding growth
US5400778A (en) * 1990-06-18 1995-03-28 Siemens-Elema Ab Method and device for reduction of rebreathing of gas from dead space
US5188602A (en) * 1990-07-12 1993-02-23 Interventional Thermodynamics, Inc. Method and device for delivering heat to hollow body organs
US5496271A (en) * 1990-09-14 1996-03-05 American Medical Systems, Inc. Combined hyperthermia and dilation catheter
US5105826A (en) * 1990-10-26 1992-04-21 Medtronic, Inc. Implantable defibrillation electrode and method of manufacture
US5730704A (en) * 1992-02-24 1998-03-24 Avitall; Boaz Loop electrode array mapping and ablation catheter for cardiac chambers
US5277201A (en) * 1992-05-01 1994-01-11 Vesta Medical, Inc. Endometrial ablation apparatus and method
US6852091B2 (en) * 1992-08-12 2005-02-08 Medtronic Vidamed, Inc. Medical probe device and method
US6379352B1 (en) * 1992-09-29 2002-04-30 Ep Technologies, Inc. Large surface cardiac ablation catherter that assumes a low profile during introduction into the heart
US5393207A (en) * 1993-01-21 1995-02-28 Nimbus, Inc. Blood pump with disposable rotor assembly
US6216044B1 (en) * 1993-03-16 2001-04-10 Ep Technologies, Inc. Medical device with three dimensional collapsible basket structure
US5893847A (en) * 1993-03-16 1999-04-13 Ep Technologies, Inc. Multiple electrode support structures with slotted hub and hoop spline elements
WO1995002370A2 (en) * 1993-07-15 1995-01-26 Aws Shakir Mustafa Salim Tunnelling catheter
US5376094A (en) * 1993-08-19 1994-12-27 Boston Scientific Corporation Improved actuating handle with pulley system for providing mechanical advantage to a surgical working element
US5507791A (en) * 1993-08-31 1996-04-16 Sit'ko; Sergei P. Microwave resonance therapy
US5496312A (en) * 1993-10-07 1996-03-05 Valleylab Inc. Impedance and temperature generator control
US6514246B1 (en) * 1993-10-14 2003-02-04 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US5599345A (en) * 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US6216043B1 (en) * 1994-03-04 2001-04-10 Ep Technologies, Inc. Asymmetric multiple electrode support structures
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5735846A (en) * 1994-06-27 1998-04-07 Ep Technologies, Inc. Systems and methods for ablating body tissue using predicted maximum tissue temperature
US5623940A (en) * 1994-08-02 1997-04-29 S.L.T. Japan Co., Ltd. Catheter apparatus with a sensor
US6214002B1 (en) * 1994-10-07 2001-04-10 Ep Technologies, Inc. Structures and methods for deploying electrode elements
US6544262B2 (en) * 1994-10-07 2003-04-08 Ep Technologies, Inc. Structures and methods for deploying electrode elements
US5707336A (en) * 1995-01-09 1998-01-13 Cardassist Incorporated Ventricular assist device
US5707218A (en) * 1995-04-19 1998-01-13 Nimbus, Inc. Implantable electric axial-flow blood pump with blood cooled bearing
US5741248A (en) * 1995-06-07 1998-04-21 Temple University-Of The Commonwealth System Of Higher Education Fluorochemical liquid augmented cryosurgery
US6837888B2 (en) * 1995-06-07 2005-01-04 Arthrocare Corporation Electrosurgical probe with movable return electrode and methods related thereto
US6179833B1 (en) * 1995-06-09 2001-01-30 Engineering & Research Associates, Inc. Apparatus for thermal ablation
US6039731A (en) * 1995-06-09 2000-03-21 Engineering & Research Associates, Inc. Apparatus and method for determining the extent of ablation
US5873852A (en) * 1995-07-10 1999-02-23 Interventional Technologies Device for injecting fluid into a wall of a blood vessel
US6023638A (en) * 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6210367B1 (en) * 1995-09-06 2001-04-03 Microwave Medical Systems, Inc. Intracorporeal microwave warming method and apparatus
US5891135A (en) * 1996-01-19 1999-04-06 Ep Technologies, Inc. Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures
US5891136A (en) * 1996-01-19 1999-04-06 Ep Technologies, Inc. Expandable-collapsible mesh electrode structures
US5727569A (en) * 1996-02-20 1998-03-17 Cardiothoracic Systems, Inc. Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery
US5728094A (en) * 1996-02-23 1998-03-17 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
WO1997032532A1 (en) * 1996-03-05 1997-09-12 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
US6033397A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6346104B2 (en) * 1996-04-30 2002-02-12 Western Sydney Area Health Service System for simultaneous unipolar multi-electrode ablation
US5876340A (en) * 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US6050992A (en) * 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US6217576B1 (en) * 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US5876399A (en) * 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US6547788B1 (en) * 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
WO1999003413A1 (en) * 1997-07-17 1999-01-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
US6014579A (en) * 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
US5891138A (en) * 1997-08-11 1999-04-06 Irvine Biomedical, Inc. Catheter system having parallel electrodes
US6045549A (en) * 1997-09-30 2000-04-04 Somnus Medical Technologies, Inc. Tissue ablation apparatus and device for use therein and method
US6200311B1 (en) * 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6355031B1 (en) * 1998-02-19 2002-03-12 Curon Medical, Inc. Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter
US6053909A (en) * 1998-03-27 2000-04-25 Shadduck; John H. Ionothermal delivery system and technique for medical procedures
US6370644B1 (en) * 1998-04-07 2002-04-09 Micron Technology, Inc. Device for blocking bus transactions during reset
US6714822B2 (en) * 1998-04-30 2004-03-30 Medtronic, Inc. Apparatus and method for expanding a stimulation lead body in situ
US7425212B1 (en) * 1998-06-10 2008-09-16 Asthmatx, Inc. Devices for modification of airways by transfer of energy
US20040031494A1 (en) * 1998-06-10 2004-02-19 Broncus Technologies, Inc. Methods of treating asthma
US6849073B2 (en) * 1998-07-07 2005-02-01 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6029091A (en) * 1998-07-09 2000-02-22 Irvine Biomedical, Inc. Catheter system having lattice electrodes
US6212433B1 (en) * 1998-07-28 2001-04-03 Radiotherapeutics Corporation Method for treating tumors near the surface of an organ
US6338727B1 (en) * 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6183468B1 (en) * 1998-09-10 2001-02-06 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6036689A (en) * 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
US6526320B2 (en) * 1998-11-16 2003-02-25 United States Surgical Corporation Apparatus for thermal treatment of tissue
US6200332B1 (en) * 1999-07-09 2001-03-13 Ceramoptec Industries, Inc. Device and method for underskin laser treatments
US20030069570A1 (en) * 1999-10-02 2003-04-10 Witzel Thomas H. Methods for repairing mitral valve annulus percutaneously
US6529756B1 (en) * 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6723091B2 (en) * 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US6840243B2 (en) * 2000-03-04 2005-01-11 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US6544226B1 (en) * 2000-03-13 2003-04-08 Curon Medical, Inc. Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body
US6673068B1 (en) * 2000-04-12 2004-01-06 Afx, Inc. Electrode arrangement for use in a medical instrument
US6689693B2 (en) * 2000-08-30 2004-02-10 Micron Technology, Inc. Methods for utilization of disappearing silicon hard mask for fabrication of semiconductor structures
US20030050631A1 (en) * 2000-12-29 2003-03-13 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US6699243B2 (en) * 2001-09-19 2004-03-02 Curon Medical, Inc. Devices, systems and methods for treating tissue regions of the body
US20030065371A1 (en) * 2001-09-28 2003-04-03 Shutaro Satake Radiofrequency thermal balloon catheter
US6692492B2 (en) * 2001-11-28 2004-02-17 Cardiac Pacemaker, Inc. Dielectric-coated ablation electrode having a non-coated window with thermal sensors
US6881213B2 (en) * 2002-06-28 2005-04-19 Ethicon, Inc. Device and method to expand treatment array
US6866662B2 (en) * 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6852110B2 (en) * 2002-08-01 2005-02-08 Solarant Medical, Inc. Needle deployment for temperature sensing from an electrode
US7186251B2 (en) * 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US20060062808A1 (en) * 2004-09-18 2006-03-23 Asthmatx, Inc. Inactivation of smooth muscle tissue
US20080004596A1 (en) * 2006-05-25 2008-01-03 Palo Alto Institute Delivery of agents by microneedle catheter
US20090018538A1 (en) * 2007-07-12 2009-01-15 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US20090030477A1 (en) * 2007-07-24 2009-01-29 Asthmatx, Inc. System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices
US20090043301A1 (en) * 2007-08-09 2009-02-12 Asthmatx, Inc. Monopolar energy delivery devices and methods for controlling current density in tissue

Cited By (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9027564B2 (en) 1997-04-07 2015-05-12 Asthmatx, Inc. Method for treating a lung
US8161978B2 (en) 1997-04-07 2012-04-24 Asthmatx, Inc. Methods for treating asthma by damaging nerve tissue
US8640711B2 (en) 1997-04-07 2014-02-04 Asthmatx, Inc. Method for treating an asthma attack
US20070106296A1 (en) * 1997-04-07 2007-05-10 Asthmatx, Inc. Expandable electode devices and methods of treating bronchial tubes
US11033317B2 (en) 1997-04-07 2021-06-15 Boston Scientific Scimed, Inc. Methods for treating a lung
US10058370B2 (en) 1997-04-07 2018-08-28 Boston Scientific Scimed, Inc. Method for treating a lung
US8944071B2 (en) 1997-04-07 2015-02-03 Asthmatx, Inc. Method for treating an asthma attack
US20090143705A1 (en) * 1997-04-07 2009-06-04 Asthmatx, Inc. Modification of airways by application of ultrasound energy
US20090192508A1 (en) * 1997-04-07 2009-07-30 Asthmatx, Inc. Modification of airways by application of mechanical energy
US9956023B2 (en) 1997-04-07 2018-05-01 Boston Scientific Scimed, Inc. System for treating a lung
US7938123B2 (en) 1997-04-07 2011-05-10 Asthmatx, Inc. Modification of airways by application of cryo energy
US8267094B2 (en) 1997-04-07 2012-09-18 Asthmatx, Inc. Modification of airways by application of ultrasound energy
US8584681B2 (en) 1998-01-07 2013-11-19 Asthmatx, Inc. Method for treating an asthma attack
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US9789331B2 (en) 1998-01-07 2017-10-17 Boston Scientific Scimed, Inc. Methods of treating a lung
US20060137698A1 (en) * 1998-06-10 2006-06-29 Asthmatx, Inc. Methods for treating airways
US20070123958A1 (en) * 1998-06-10 2007-05-31 Asthmatx, Inc. Apparatus for treating airways in the lung
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US8733367B2 (en) 1998-06-10 2014-05-27 Asthmatx, Inc. Methods of treating inflammation in airways
US8443810B2 (en) 1998-06-10 2013-05-21 Asthmatx, Inc. Methods of reducing mucus in airways
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US8534291B2 (en) 1998-06-10 2013-09-17 Asthmatx, Inc. Methods of treating inflammation in airways
US8464723B2 (en) 1998-06-10 2013-06-18 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US10561458B2 (en) 2000-03-27 2020-02-18 Boston Scientific Scimed, Inc. Methods for treating airways
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US10278766B2 (en) 2000-03-27 2019-05-07 Boston Scientific Scimed, Inc. Methods for treating airways
US8459268B2 (en) 2000-03-27 2013-06-11 Asthmatx, Inc. Methods for treating airways
US9358024B2 (en) 2000-03-27 2016-06-07 Asthmatx, Inc. Methods for treating airways
US9931163B2 (en) 2000-10-17 2018-04-03 Boston Scientific Scimed, Inc. Energy delivery devices
US8888769B2 (en) 2000-10-17 2014-11-18 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US9033976B2 (en) 2000-10-17 2015-05-19 Asthmatx, Inc. Modification of airways by application of energy
US8465486B2 (en) 2000-10-17 2013-06-18 Asthmatx, Inc. Modification of airways by application of energy
US7854734B2 (en) 2000-10-17 2010-12-21 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US7837679B2 (en) 2000-10-17 2010-11-23 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US20070100390A1 (en) * 2000-10-17 2007-05-03 Asthmatx, Inc. Modification of airways by application of energy
US8257413B2 (en) 2000-10-17 2012-09-04 Asthmatx, Inc. Modification of airways by application of energy
US10016592B2 (en) 2001-10-17 2018-07-10 Boston Scientific Scimed, Inc. Control system and process for application of energy to airway walls and other mediums
US8172827B2 (en) 2003-05-13 2012-05-08 Innovative Pulmonary Solutions, Inc. Apparatus for treating asthma using neurotoxin
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US10953170B2 (en) 2003-05-13 2021-03-23 Nuvaira, Inc. Apparatus for treating asthma using neurotoxin
US10076380B2 (en) 2004-11-05 2018-09-18 Boston Scientific Scimed, Inc. Energy delivery devices and methods
US8480667B2 (en) 2004-11-05 2013-07-09 Asthmatx, Inc. Medical device with procedure improvement features
US7853331B2 (en) 2004-11-05 2010-12-14 Asthmatx, Inc. Medical device with procedure improvement features
US10398502B2 (en) 2004-11-05 2019-09-03 Boston Scientific Scimed, Inc. Energy delivery devices and methods
US20070106292A1 (en) * 2004-11-05 2007-05-10 Asthmatx, Inc. Energy delivery devices and methods
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
US20060247619A1 (en) * 2004-11-05 2006-11-02 Asthmatx, Inc. Medical device with procedure improvement features
US20070123961A1 (en) * 2004-11-12 2007-05-31 Asthmax, Inc. Energy delivery and illumination devices and methods
US8920413B2 (en) 2004-11-12 2014-12-30 Asthmatx, Inc. Energy delivery devices and methods
US7931647B2 (en) 2006-10-20 2011-04-26 Asthmatx, Inc. Method of delivering energy to a lung airway using markers
US10368941B2 (en) 2007-07-12 2019-08-06 Boston Scientific Scimed, Inc. Systems and methods for delivering energy to passageways in a patient
US8235983B2 (en) * 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US11478299B2 (en) 2007-07-12 2022-10-25 Boston Scientific Scimed, Inc. Systems and methods for delivering energy to passageways in a patient
US8731672B2 (en) 2008-02-15 2014-05-20 Holaira, Inc. System and method for bronchial dilation
US8489192B1 (en) 2008-02-15 2013-07-16 Holaira, Inc. System and method for bronchial dilation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US9125643B2 (en) 2008-02-15 2015-09-08 Holaira, Inc. System and method for bronchial dilation
US11058879B2 (en) 2008-02-15 2021-07-13 Nuvaira, Inc. System and method for bronchial dilation
US8226638B2 (en) 2008-05-09 2012-07-24 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9668809B2 (en) 2008-05-09 2017-06-06 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8808280B2 (en) 2008-05-09 2014-08-19 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8821489B2 (en) 2008-05-09 2014-09-02 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961507B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US10149714B2 (en) 2008-05-09 2018-12-11 Nuvaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US20100160906A1 (en) * 2008-12-23 2010-06-24 Asthmatx, Inc. Expandable energy delivery devices having flexible conductive elements and associated systems and methods
US9649153B2 (en) 2009-10-27 2017-05-16 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9675412B2 (en) 2009-10-27 2017-06-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9017324B2 (en) 2009-10-27 2015-04-28 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9005195B2 (en) 2009-10-27 2015-04-14 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8777943B2 (en) 2009-10-27 2014-07-15 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9931162B2 (en) 2009-10-27 2018-04-03 Nuvaira, Inc. Delivery devices with coolable energy emitting assemblies
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US10610283B2 (en) 2009-11-11 2020-04-07 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US11712283B2 (en) 2009-11-11 2023-08-01 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US11389233B2 (en) 2009-11-11 2022-07-19 Nuvaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9649154B2 (en) 2009-11-11 2017-05-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US20120116378A1 (en) * 2010-04-26 2012-05-10 Minerva Surgical, Inc. Endometrial ablation with a device that conforms to symmetric or asymmetric uterine cavities
US9770293B2 (en) 2012-06-04 2017-09-26 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
US9592086B2 (en) 2012-07-24 2017-03-14 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9572619B2 (en) 2012-11-02 2017-02-21 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9283374B2 (en) 2012-11-05 2016-03-15 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US10492859B2 (en) 2012-11-05 2019-12-03 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9974609B2 (en) 2012-11-05 2018-05-22 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
US10478247B2 (en) 2013-08-09 2019-11-19 Boston Scientific Scimed, Inc. Expandable catheter and related methods of manufacture and use
US11801090B2 (en) 2013-08-09 2023-10-31 Boston Scientific Scimed, Inc. Expandable catheter and related methods of manufacture and use
US20150265458A1 (en) * 2014-02-21 2015-09-24 Circuit Therapeutics, Inc. System and method for therapeutic management of unproductive cough
US10858735B2 (en) 2014-09-10 2020-12-08 Applied Materials, Inc. Alignment systems employing actuators providing relative displacement between lid assemblies of process chambers and substrates, and related methods
US10939958B2 (en) 2016-06-27 2021-03-09 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US11369433B2 (en) 2016-06-27 2022-06-28 Galvanize Therapeutics, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
CN107374725A (en) * 2017-08-31 2017-11-24 苏州信迈医疗器械有限公司 A kind of multipole ablating device
CN111227929A (en) * 2018-11-29 2020-06-05 上海安臻医疗科技有限公司 Adjustable bronchus thermoforming pipe
US20210038289A1 (en) * 2019-08-05 2021-02-11 Karl Storz Se & Co. Kg Endoscopic device

Also Published As

Publication number Publication date
US7425212B1 (en) 2008-09-16

Similar Documents

Publication Publication Date Title
US7425212B1 (en) Devices for modification of airways by transfer of energy
CA2370223C (en) Modification of airways by application of energy
US9931163B2 (en) Energy delivery devices
CA2426144C (en) Modification of airways by application of energy
US10058370B2 (en) Method for treating a lung
AU2001212109A1 (en) Modification of airways by application of energy
US20180360537A1 (en) Energy delivery devices and methods
US10016592B2 (en) Control system and process for application of energy to airway walls and other mediums
US9789331B2 (en) Methods of treating a lung
US6411852B1 (en) Modification of airways by application of energy
US20020004644A1 (en) Methods of deploying helical diagnostic and therapeutic element supporting structures within the body

Legal Events

Date Code Title Description
AS Assignment

Owner name: ASTHMATX, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRONCUS TECHNOLOGIES, INC.;REEL/FRAME:022886/0969

Effective date: 20031226

Owner name: BRONCUS TECHNOLOGIES, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DANEK, CHRISTOPHER JAMES;LOOMAS, BRYAN;BIGGS, MICHAEL;AND OTHERS;REEL/FRAME:022886/0942;SIGNING DATES FROM 20000211 TO 20000314

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASTHMATX, INC.;REEL/FRAME:040510/0149

Effective date: 20101026

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION